Viral pneumonia (unknown virus, not influenza)

VIRALPNEUMONAS

viral pneumonia: Inflammation of the lung parenchyma that is caused by a viral infection.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J12.8, J12.9 Hospital discharge: ICD-9 — 480 Hospital discharge: ICD-8 — 480 Hospital discharge: excluded ICD-9 — 480[0-2] Cause of death: ICD-10 — J12.8, J12.9 Cause of death: ICD-9 — 480 Cause of death: ICD-8 — 480 Cause of death: excluded ICD-9 — 480[0-2] 2 out of 7 registries used, show all original rules.	3257
4. Check minimum number of events None	3257
5. Include endpoints None	3257
6. Filter based on genotype QC (FinnGen only)	2840

Control definitions (FinnGen only)

Control exclude: ASTHMA_PNEUMONIA

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	VIRALPNEUMONAS
CONTROL_EXCLUDE	ASTHMA_PNEUMONIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J128\|J129
HD_ICD_9	480
HD_ICD_8	480
HD_ICD_10_EXCL
HD_ICD_9_EXCL	480[0-2]
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J128\|J129
COD_ICD_9	480
COD_ICD_8	480
COD_ICD_10_EXCL
COD_ICD_9_EXCL	480[0-2]
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Viral pneumonia (unknown virus, not influenza) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	22206	9354	12641
Only index persons	17921	7501	10420
Unadjusted period prevalence (%)
Whole population	0.32	0.27	0.35
Only index persons	0.35	0.28	0.40
Median age at first event (years)
Whole population	26.87	35.15	20.24
Only index persons	21.48	24.06	19.62

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2840	1342	1498
Unadjusted period prevalence (%)	0.59	0.48	0.69
Median age at first event (years)	56.55	52.90	59.83

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3013: Matched controls
30130

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

48099

ICD-8 Finland

Viral pneumonia

+∞

307.7

338

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

9.1

307.7

1724

3875

J12.8

ICD-10 Finland

Other viral pneumonia

5205.5

307.7

1490

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

1343.2

307.7

865

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.9

307.7

1344

4226

4809X

ICD-9 Finland

Viral pneumonia, unspecified

+∞

276.4

261

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.4

175.9

795

2844

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

5.8

159.6

314

596

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

14.9

141.3

127

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

4.2

140.4

410

1079

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

129.8

1652

9852

J45.9

ICD-10 Finland

Asthma, unspecified

3.0

128.5

686

2660

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.9

123.2

704

2828

H02AB06

ATC

prednisolone; systemic

2.3

104.5

1571

9757

L04AA06

ATC

mycophenolic acid; systemic

7.5

102.9

150

208

C03CA01

ATC

furosemide; systemic

2.4

99.2

969

4993

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.2

97.1

439

1529

TGC00

NOMESCO Finland

Bronchial lavation

6.8

96.0

154

237

R06.0

ICD-10 Finland

Dyspnoea

2.3

92.7

945

4935

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.6

92.7

329

983

J45.1

ICD-10 Finland

Nonallergic asthma

4.1

92.0

273

720

R50.9

ICD-10 Finland

Fever, unspecified

2.6

91.7

641

2816

XF400

NOMESCO Finland

ECG with 12 standard connections

2.7

91.6

598

2540

R03AC02

ATC

salbutamol; inhalant

2.1

88.5

1763

11946

GD1AD

NOMESCO Finland

Thorax CT examination

3.8

87.7

287

811

127

Kela drug reimbursment

Transplant complication

7.5

87.1

127

176

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.0

86.4

443

1652

R03BB04

ATC

tiotropium bromide; inhalant

3.4

86.4

350

1137

R4110

NOMESCO Finland

Physiotherapy

2.2

85.8

968

5244

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.6

84.6

307

929

4808X

ICD-9 Finland

Viral pneumonia, Pneumonia due to other virus not elsewhere classified

+∞

79.5

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.4

75.9

627

2954

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

5.5

75.5

151

288

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.3

74.8

683

3359

U08.9

ICD-10 Finland

Personal history of COVID-19, unspecified

13.6

73.4

Z29.8

ICD-10 Finland

Other specified prophylactic measures

4.6

73.4

179

405

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.1

73.3

329

1133

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

72.3

776

4076

J45

ICD-10 Finland

Asthma

2.9

69.2

373

1422

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

4.4

69.0

178

421

J01MA14

ATC

moxifloxacin; systemic

3.0

67.4

335

1221

L04AD02

ATC

tacrolimus; systemic

8.0

67.4

118

J01MA12

ATC

levofloxacin; systemic

2.3

63.7

604

2998

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.2

62.9

264

871

I50.9

ICD-10 Finland

Heart failure, unspecified

2.5

62.8

451

1979

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.5

61.2

442

1943

R02

ICPC

Shortness of breath/dyspnoea

2.4

59.9

470

2145

J46

ICD-10 Finland

Status asthmaticus

5.7

59.4

112

202

ZX108

NOMESCO Finland

Inhalation

11.3

58.0

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

4.3

57.9

152

364

ZXE00

NOMESCO Finland

One hour or less

1.9

57.5

1189

7772

R03BA02

ATC

budesonide; inhalant

2.2

56.4

565

2854

R03DA04

ATC

theophylline; systemic, rectal

3.9

56.0

168

444

R81

ICPC

Pneumonia

4.0

55.0

161

418

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.9

53.7

121

256

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

4.6

53.2

129

290

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

53.0

1639

12013

R03DC03

ATC

montelukast; oral

2.2

52.3

508

2528

R03AC03

ATC

terbutaline; inhalant

2.3

52.0

440

2068

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.9

51.7

258

938

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

7.5

50.5

100

R83

ICPC

Respiratory infection other

1.9

49.8

877

5393

ZX120

NOMESCO Finland

Intravenous

2.5

49.4

327

1373

TK800

NOMESCO Finland

Hemodialysis

4.8

49.0

112

240

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.1

48.6

588

3177

R03AK07

ATC

formoterol and budesonide; inhalant

2.0

48.3

658

3709

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.5

48.3

175

526

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.6

48.1

292

1175

J96.1

ICD-10 Finland

Chronic respiratory failure

5.6

47.1

168

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

46.8

1044

6879

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.6

45.9

112

253

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.3

45.8

180

569

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.9

45.2

228

833

R03BA05

ATC

fluticasone; inhalant

2.0

44.9

542

2919

R03AC12

ATC

salmeterol; inhalant

3.9

44.9

136

362

WX730

NOMESCO Finland

Conventional respirator

6.0

44.8

137

Z94.0

ICD-10 Finland

Kidney transplant status

6.2

44.8

127

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

5.6

44.6

155

Z2221

NOMESCO Finland

Medical doctor

1.8

44.6

823

5108

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

44.4

903

5769

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

4.0

44.4

131

342

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

44.3

1601

12018

ZXD10

NOMESCO Finland

Scheduled procedure

1.8

44.2

1085

7321

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

7.3

44.1

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

43.8

456

2321

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.4

43.8

323

1424

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

6.6

42.6

107

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.8

42.4

134

367

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

4.2

41.9

113

276

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.5

41.1

145

428

J45.8

ICD-10 Finland

Mixed asthma

4.3

40.9

106

251

A46

ICD-10 Finland

Erysipelas

2.1

40.9

468

2465

A41.9

ICD-10 Finland

Sepsis, unspecified

3.6

40.9

141

410

XW000

NOMESCO Finland

Bone marrow biopsy

3.2

40.7

165

531

Z3231

NOMESCO Finland

Registered nurse

1.8

40.6

814

5156

A02BC02

ATC

pantoprazole; systemic

1.7

40.4

1960

15735

AA1AD

NOMESCO Finland

CT of head and brain

1.8

40.3

847

5436

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

40.2

771

4816

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

40.1

412

2082

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

39.4

417

2131

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

4.6

39.3

205

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.9

39.0

187

664

A28

ICPC

Limited function/disability NOS

2.0

39.0

518

2874

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

38.8

363

1767

B34.2

ICD-10 Finland

Coronavirus infection, unspecified site

7.4

38.6

J01FA06

ATC

roxithromycin; oral

1.7

38.4

1098

7654

N02AX02

ATC

tramadol; systemic, rectal

1.7

38.1

1227

8816

H02AB04

ATC

methylprednisolone; systemic

2.1

38.0

408

2094

N18.0

ICD-10 Finland

End-stage renal disease

6.8

37.8

L28

ICPC

Limited function/disability (L)

1.9

37.7

546

3115

ZXD05

NOMESCO Finland

Urgent procedure

1.7

37.7

884

5836

N03AX16

ATC

[U] pregabalin

1.8

37.6

652

3939

R60.0

ICD-10 Finland

Localized oedema

2.1

37.4

385

1944

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.3

37.2

310

1438

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.7

37.0

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.4

36.9

134

403

B01AB05

ATC

enoxaparin; parenteral

1.7

36.7

864

5701

N18.8

ICD-10 Finland

Other chronic renal failure

4.1

36.7

102

255

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.7

36.7

202

772

JN4AD

NOMESCO Finland

Body CT examination

2.2

36.6

360

1785

Z29.0

ICD-10 Finland

Isolation

13.7

36.5

TPH07

NOMESCO Finland

Cathetrisation of artery

2.2

36.2

355

1758

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.7

36.1

209

819

I50.0

ICD-10 Finland

Congestive heart failure

2.6

36.0

219

880

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.3

36.0

141

WX892

NOMESCO Finland

Monitored bed care

2.4

36.0

260

1133

XF600

NOMESCO Finland

Bloodpressure measurement

2.6

35.7

222

901

J01FF01

ATC

clindamycin; systemic

1.7

35.4

792

5145

C07AB07

ATC

bisoprolol; oral

1.6

35.2

1313

9731

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.3

34.9

135

422

B03XA02

ATC

darbepoetin alfa; parenteral

4.0

34.9

101

260

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

14.1

34.8

H02AB07

ATC

prednisone; oral

2.1

34.8

377

1939

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

34.7

814

5353

J01AA02

ATC

doxycycline; systemic

1.7

34.5

2171

18237

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.9

34.2

167

598

J20

ICD-10 Finland

Acute bronchitis

2.2

33.8

323

1582

J96.0

ICD-10 Finland

Acute respiratory failure

5.7

33.6

113

WX402

NOMESCO Finland

General anaesthesia

1.7

33.3

688

4358

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

32.8

386

2043

R05

ICPC

Cough

1.7

32.8

733

4744

J15.8

ICD-10 Finland

Other bacterial pneumonia

9.4

32.7

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

5.9

32.3

100

R53

ICD-10 Finland

Malaise and fatigue

1.7

31.9

762

5016

A03

ICPC

Fever

1.8

31.8

569

3453

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.7

31.7

102

283

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

6.0

31.7

Z3226

NOMESCO Finland

Physiotherapist

1.8

31.6

523

3099

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

4.2

31.5

208

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

4.4

31.4

183

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

7.0

31.4

WW200

NOMESCO Finland

Immunization

3.4

31.4

114

343

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.5

31.2

200

823

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

31.0

477

2762

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

30.3

585

3625

A11CC03

ATC

alfacalcidol; systemic

3.6

30.2

278

H02AB09

ATC

hydrocortisone; systemic

3.6

30.1

102

293

R03AK08

ATC

formoterol and beclometasone; inhalant

3.0

30.1

139

483

J01CA04

ATC

amoxicillin; systemic

1.7

30.0

2432

21325

V03AE02

ATC

sevelamer; oral

8.4

30.0

TK810

NOMESCO Finland

Hemofiltration

8.4

30.0

WX726

NOMESCO Finland

High-flow oxygen therapy

32.9

30.0

A12AA04

ATC

calcium carbonate; oral

4.5

29.9

165

J01DB01

ATC

cefalexin; oral

1.7

29.3

2418

21210

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

28.7

794

5406

Z2446

NOMESCO Finland

Social worker

2.3

28.6

220

983

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

7.9

28.5

GD2SN

NOMESCO Finland

Lung ventilation SPECT

7.6

28.5

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

6.9

28.4

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.2

28.4

113

360

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.4

28.3

209

918

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

10.1

28.3

Z71.8

ICD-10 Finland

Other specified counselling

1.6

28.1

1006

7276

M04AA01

ATC

allopurinol; systemic

1.9

28.1

370

2031

49300

ICD-8 Finland

Asthma, bronchiale

4.4

27.9

162

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.5

27.6

151

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

8.6

27.5

A10AB05

ATC

insulin aspart; parenteral

2.2

27.5

253

1219

R03BB01

ATC

ipratropium bromide; inhalant

3.3

27.4

102

312

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.2

26.9

227

1056

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.8

26.8

141

526

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

6.0

26.5

J01MA02

ATC

ciprofloxacin; systemic

1.5

26.3

1056

7813

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.4

26.0

187

812

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

4.1

25.9

176

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

25.7

651

4320

R03AC13

ATC

formoterol; inhalant

2.7

25.3

136

513

C08CA01

ATC

amlodipine; oral

1.5

25.3

995

7314

TKC20

NOMESCO Finland

Catheterisation of bladder

2.3

25.3

202

918

R06AE07

ATC

cetirizine; oral

1.5

25.2

1207

9247

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

6.6

25.1

196

Kela drug reimbursment

Paricalcitol and cinacalcet

7.7

25.1

E66.8

ICD-10 Finland

Other obesity

2.4

24.8

173

740

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

24.6

1025

7614

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

24.6

669

4511

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.3

24.6

185

819

S97

ICPC

Chronic ulcer skin

2.3

24.3

189

848

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.1

24.3

100

325

GD1UN

NOMESCO Finland

Lung circulation SPECT

7.9

24.3

WX002

NOMESCO Finland

Sedation and analgesia

1.7

24.3

513

3241

WW500

NOMESCO Finland

Blood transfusion

2.7

24.2

135

519

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.2

24.0

202

938

R96

ICPC

Asthma

2.1

24.0

254

1290

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

23.9

862

6201

R03AK11

ATC

formoterol and fluticasone; inhalant

3.5

23.8

234

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.9

23.7

179

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

5.4

23.5

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.4

23.3

165

711

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

23.2

172

756

B01AB10

ATC

tinzaparin; parenteral

1.9

23.2

304

1663

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

23.1

570

3745

A02BC01

ATC

omeprazole; systemic

1.6

23.1

705

4878

G47.3

ICD-10 Finland

Sleep apnoea

1.6

23.0

665

4539

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

5.0

23.0

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.7

22.9

125

475

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.6

22.5

209

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

22.4

1217

9499

A06AD11

ATC

lactulose; oral

1.8

22.4

390

2331

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

3.7

22.3

196

N02BE01

ATC

paracetamol; systemic, rectal

1.7

22.2

2560

23237

E66.01

ICD-10 Finland

Obesity due to excess calories

1.9

22.1

282

1527

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

22.1

687

4765

L04AD01

ATC

ciclosporin; systemic

3.6

22.0

207

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

22.0

2083

18065

J01FA10

ATC

azithromycin; systemic

1.5

22.0

1607

13254

SPAT1255

SPAT

Intravenous administration of medicine

2.2

21.9

194

919

48609

ICD-8 Finland

Pneumonia, unspecified

4.3

21.9

136

L04AX01

ATC

azathioprine; systemic

2.5

21.9

140

576

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

21.6

362

2136

N30.0

ICD-10 Finland

Acute cystitis

1.7

21.6

441

2752

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

21.6

773

5527

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

21.6

623

4246

R03BA01

ATC

beclometasone; inhalant

1.8

21.5

342

1989

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.4

21.3

153

663

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.3

21.2

159

703

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

20.9

706

4979

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

20.9

1047

8012

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.2

20.9

190

910

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

6.9

20.8

321

Kela drug reimbursment

Paricalcitol and cinacalcet

6.1

20.8

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.1

20.8

E0000UV, ,

ATC

1.5

20.8

1144

8915

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

20.5

412

2558

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.4

20.5

142

606

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.5

20.5

203

R60.9

ICD-10 Finland

Oedema, unspecified

2.3

20.4

163

741

137

Kela drug reimbursment

Uraemia requiring dialysis

4.8

20.3

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

5.5

20.2

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.6

20.2

604

4144

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

19.9

144

627

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

19.7

1172

9239

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

19.6

184

892

XG410

NOMESCO Finland

Flow-volume spirometry

2.6

19.5

112

437

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

3.6

19.5

176

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

19.3

291

1661

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.8

19.3

100

370

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

8.4

19.3

V03AE01

ATC

polystyrene sulfonate; oral

4.0

19.1

137

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

1.9

19.1

245

1329

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

19.1

329

1956

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

7.2

19.1

A02BC05

ATC

esomeprazole; systemic

1.4

19.0

1045

8103

N17.8

ICD-10 Finland

Other acute renal failure

4.1

18.9

125

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

18.9

1175

9317

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

18.9

261

1450

ZXA00

NOMESCO Finland

Right side

1.5

18.8

650

4593

WVA20

NOMESCO Finland

Medicine administration

2.7

18.7

371

B01AF02

ATC

apixaban; oral

1.7

18.5

346

2103

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

18.3

250

1385

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

6.9

18.2

38100

ICD-8 Finland

Otitis media without mention of mastoiditis, Acute

3.0

18.2

276

R4190

NOMESCO Finland

Nutritional therapy

2.4

18.2

129

557

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

3.6

18.0

162

B01AB04

ATC

dalteparin; parenteral

2.3

17.9

141

637

J01FA09

ATC

clarithromycin; systemic

1.5

17.8

801

5965

R52.9

ICD-10 Finland

Pain, unspecified

1.8

17.8

291

1702

J47

ICD-10 Finland

Bronchiectasis

3.9

17.8

131

WX110, ,

SPAT

2.1

17.7

180

899

C03DA01

ATC

spironolactone; oral

1.8

17.7

308

1834

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

17.7

570

3964

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.9

17.7

292

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.3

17.5

135

604

WX872

NOMESCO Finland

Intensive care

2.2

17.5

150

702

J01CF05

ATC

flucloxacillin; systemic

1.9

17.4

214

1143

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

5.9

17.4

N19

ICD-10 Finland

Unspecified kidney failure

2.5

17.4

110

450

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

7.8

17.4

WX213

NOMESCO Finland

Lower leg blockade

5.0

17.3

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.9

17.3

284

A10AE04

ATC

insulin glargine; parenteral

1.8

17.3

274

1587

Z94.2

ICD-10 Finland

Lung transplant status

24.2

17.3

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

4.6

17.3

A10AC01

ATC

insulin (human); parenteral

1.9

17.3

214

1147

H05BX01

ATC

cinacalcet; oral

5.7

17.3

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

6.2

17.2

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.8

17.1

325

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.2

17.1

207

JN4BD

NOMESCO Finland

Extensive body CT

1.8

17.0

256

1461

SPAT1229

SPAT

Assessment of need for aid

2.0

16.9

189

977

J01DA06

ATC

[U] cefuroxime

1.7

16.9

361

2274

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

16.9

1530

12857

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

16.8

348

2174

R11

ICD-10 Finland

Nausea and vomiting

1.8

16.8

248

1407

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

16.8

196

1030

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

16.7

307

1857

N02BF02

ATC

pregabalin; oral

2.0

16.5

188

979

L04AX04

ATC

lenalidomide; oral

5.6

16.5

R51.80

ICD-10 Finland

Headache

1.6

16.5

434

2878

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

4.0

16.5

116

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

16.4

282

1673

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

4.4

16.4

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.0

16.4

239

R03DC01

ATC

zafirlukast; oral

4.1

16.3

108

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

5.7

16.3

M10.9

ICD-10 Finland

Gout, unspecified

1.9

16.3

195

1033

N05BA04

ATC

oxazepam; oral

1.5

16.2

677

4955

EB1AA, ,

SPAT

1.9

16.2

194

1028

153

Kela drug reimbursment

Lenalidomid

5.5

16.2

A23

ICPC

Risk factor NOS

1.7

16.2

290

1741

GDG10

NOMESCO Finland

Bilateral transplantation of lung

30.2

16.1

N05BA01

ATC

diazepam; systemic, rectal

1.7

16.1

326

2024

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.9

16.1

263

R04.2

ICD-10 Finland

Haemoptysis

2.6

16.1

377

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

16.0

124

557

R05

ICD-10 Finland

Cough

1.5

16.0

563

3982

B05DB

ATC

Hypertonic solutions

5.0

15.9

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

15.9

483

3307

R74

ICPC

Upper respiratory infection acute

1.4

15.9

925

7194

B01AA03

ATC

warfarin; systemic

1.6

15.9

444

2983

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.9

15.7

213

1175

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.9

15.7

250

T90

ICPC

Diabetes non-insulin dependent

1.5

15.7

603

4338

N06AX11

ATC

mirtazapine; oral

1.4

15.7

896

6946

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

15.6

496

3430

KBV00

NOMESCO Finland

Insertion of stent into ureter

5.3

15.6

E87.5

ICD-10 Finland

Hyperkalaemia

3.3

15.6

183

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

15.5

222

1246

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

15.5

281

1693

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

6.2

15.5

ZY010

NOMESCO Finland

Hospital outpatient

2.0

15.2

162

823

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.2

15.2

196

C08CA02

ATC

felodipine; oral

1.8

15.2

230

1314

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

5.3

15.1

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.2

15.1

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

15.1

242

1407

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

15.0

245

1431

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

15.0

535

3787

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

15.0

798

6100

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.4

15.0

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

15.0

275

1662

R42

ICD-10 Finland

Dizziness and giddiness

1.5

15.0

571

4099

329

Kela drug reimbursment

Lenalidomide

5.8

14.9

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.2

14.8

189

R03CC02

ATC

salbutamol; systemic

1.9

14.8

182

974

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

14.6

802

6156

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.6

14.6

131

R03BA08

ATC

ciclesonide; inhalant

1.8

14.6

211

1188

J128, U071,

ICD-10 Finland

+∞

14.6

207

Kela drug reimbursment

Chronic arrhythmias

1.6

14.5

371

2439

L03AA02

ATC

filgrastim; parenteral

2.5

14.5

348

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.6

14.4

128

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.2

14.4

122

569

UKC02

NOMESCO Finland

Cystoscopy

1.6

14.3

400

2684

J01DA01

ATC

[U] cefalexin

1.3

14.3

1633

14075

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.5

14.3

143

Z49.2

ICD-10 Finland

Other dialysis

4.5

14.2

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

6.2

14.2

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

14.1

213

1216

R03BC01

ATC

cromoglicic acid; inhalant

3.3

14.1

159

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.0

14.1

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

14.0

463

3225

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

14.0

113

517

J01FA01

ATC

erythromycin; systemic

1.6

13.9

358

2357

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.2

13.8

176

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

13.8

633

4699

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

13.8

277

1715

C90.0

ICD-10 Finland

Multiple myeloma

3.7

13.7

118

B34.9

ICD-10 Finland

Viral infection, unspecified

2.3

13.7

432

XG466

NOMESCO Finland

Sleep oxymetry

2.5

13.7

340

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

13.6

362

2402

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

5.9

13.5

A97

ICPC

No disease

1.5

13.5

541

3913

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

13.5

355

2348

ZY000

NOMESCO Finland

Hospital inpatient

3.2

13.4

164

49099

ICD-8 Finland

Bronchitis, unspecified

4.2

13.4

N05CF01

ATC

zopiclone; oral

1.4

13.4

782

6056

A07AA02

ATC

nystatin; oral

2.0

13.3

136

681

S29

ICPC

Skin symptom/complaint other

1.5

13.3

522

3758

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.4

13.3

135

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

13.3

217

1268

R33

ICD-10 Finland

Retention of urine

1.8

13.3

209

1208

SPAT1262

SPAT

Handing over of treatment supplies

1.5

13.3

423

2920

S76

ICPC

Skin infection other

2.0

13.2

150

780

N03AX12

ATC

[U] gabapentin; oral

1.5

13.2

390

2647

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

13.2

190

1069

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.1

13.2

126

616

B05DA

ATC

Isotonic solutions

4.2

13.2

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.4

13.1

365

ZXA05

NOMESCO Finland

Left side

1.4

13.0

575

4233

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.8

13.0

226

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.3

13.0

410

A10AE05

ATC

insulin detemir; parenteral

2.0

13.0

148

771

M79.6

ICD-10 Finland

Pain in limb

1.3

13.0

1132

9324

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

3.3

13.0

152

J20.6

ICD-10 Finland

Acute bronchitis due to rhinovirus

28.5

12.9

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.6

12.9

278

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

4.4

12.9

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

12.9

584

4322

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

4.5

12.8

UJF32

NOMESCO Finland

Coloscopy

1.4

12.8

626

4696

K07

ICPC

Swollen ankles/oedema

2.1

12.8

120

583

N05AH04

ATC

quetiapine; oral

1.5

12.8

479

3418

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

12.7

727

5600

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.3

12.7

149

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.9

12.7

202

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

2.7

12.6

258

A10BA02

ATC

metformin; oral

1.4

12.6

690

5274

R06.2

ICD-10 Finland

Wheezing

2.1

12.6

119

580

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

12.5

377

2569

N02AA05

ATC

oxycodone; systemic

1.5

12.5

441

3106

P01BA02

ATC

hydroxychloroquine; oral

1.8

12.5

187

1064

X58

ICD-10 Finland

Exposure to other specified factors

1.5

12.5

420

2930

A04

ICPC

Weakness/tiredness general

1.5

12.5

427

2990

NHQ40

NOMESCO Finland

Amputation of toe

3.3

12.4

146

R29

ICPC

Respiratory symptom/complaint other

1.8

12.4

186

1060

ZXA10

NOMESCO Finland

Bilateral

1.5

12.4

429

3011

W19

ICD-10 Finland

Unspecified fall

1.6

12.4

265

1667

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

4.7

12.3

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

12.3

147

778

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.9

12.3

194

A41.8

ICD-10 Finland

Other specified sepsis

2.9

12.3

189

R01AD09

ATC

mometasone; nasal

1.3

12.3

1165

9693

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

12.1

490

3544

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

12.0

607

4572

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

21.4

12.0

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.4

12.0

362

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.5

12.0

301

L17

ICPC

Foot/toe symptom/complaint

1.4

11.9

780

6132

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.3

11.9

135

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

11.9

856

6831

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

11.9

201

1187

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

11.9

233

1433

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

11.9

341

2300

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

11.9

105

499

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.0

11.8

134

697

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

11.8

266

1694

S21

ICPC

Skin texture symptom/complaint

1.5

11.8

379

2619

L04AA01

ATC

[U] ciclosporin

3.4

11.8

126

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

11.7

142

756

L04AA13

ATC

[U] leflunomide

2.6

11.7

245

J43.9

ICD-10 Finland

Emphysema, unspecified

3.2

11.6

137

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.0

11.6

132

688

J05AB01

ATC

aciclovir; systemic

1.4

11.6

538

3990

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.8

11.6

170

963

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.0

11.5

121

613

Z01.7

ICD-10 Finland

Laboratory examination

1.5

11.5

439

3139

J80

ICD-10 Finland

Adult respiratory distress syndrome

9.3

11.5

N03AE01

ATC

clonazepam; systemic

1.9

11.4

143

770

ZXD20

NOMESCO Finland

Day surgery

1.6

11.4

304

2016

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

11.4

147

800

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

11.4

371

2571

R4180

NOMESCO Finland

Podiatric therapy

3.3

11.4

129

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.0

11.3

160

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.8

11.3

198

H66.9

ICD-10 Finland

Otitis media, unspecified

1.7

11.3

189

1112

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

11.3

327

2210

N06AX16

ATC

venlafaxine; oral

1.5

11.2

359

2478

J02AC01

ATC

fluconazole; systemic

1.3

11.2

881

7114

I50.1

ICD-10 Finland

Left ventricular failure

2.0

11.1

118

601

R52.0

ICD-10 Finland

Acute pain

2.2

11.1

446

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

11.0

544

4075

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

11.0

229

1429

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

11.0

259

1667

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

11.0

133

708

SPAT1254

SPAT

Administration of medicine

1.5

11.0

366

2545

N06AB04

ATC

citalopram; systemic

1.4

11.0

487

3579

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

11.0

118

603

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.1

11.0

103

501

H3603, E103,

ICD-10 Finland

3.4

11.0

112

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.7

10.9

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

10.9

274

1790

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.0

10.9

119

611

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

10.9

103

502

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

10.9

215

1325

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

10.8

234

1475

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

10.8

323

2195

WZC30

NOMESCO Finland

Teaching

1.5

10.8

407

2901

GX2D5

NOMESCO Finland

Sleep oximetry

4.2

10.8

N05CD07

ATC

temazepam; oral

1.6

10.8

256

1651

N05AA02

ATC

levomepromazine; systemic

2.1

10.8

105

518

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.4

10.8

292

R4120

NOMESCO Finland

Occupational therapy

1.8

10.7

169

978

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

3.5

10.7

104

C09AA05

ATC

ramipril; oral

1.4

10.7

574

4360

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.9

10.7

143

787

XF404

NOMESCO Finland

Ambulatory ECG

1.7

10.7

209

1285

46599

ICD-8 Finland

Acute upper respiratory infection of multiple or unspecified sites

1.9

10.7

143

788

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

10.6

371

2605

J18.2

ICD-10 Finland

Hypostatic pneumonia, unspecified

60.2

10.6

R01AD08

ATC

fluticasone; nasal

1.4

10.6

705

5544

A07DA03

ATC

loperamide; oral

2.3

10.6

338

N06AX21

ATC

duloxetine; oral

1.5

10.5

294

1969

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

10.5

168

976

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

10.5

196

1190

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.1

10.5

100

490

R04.0

ICD-10 Finland

Epistaxis

1.7

10.4

189

1138

48009, ,

ICD-8 Finland

+∞

10.4

R28

ICPC

Limited function/disability (R)

3.3

10.4

121

S06.0

ICD-10 Finland

Concussion

1.5

10.4

288

1927

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

10.3

165

959

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.1

10.3

439

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

10.3

181

1080

WX722

NOMESCO Finland

PEEP

2.0

10.3

115

597

Z51.5

ICD-10 Finland

Palliative care

1.7

10.2

202

1244

A04AA01

ATC

ondansetron; systemic, rectal

1.7

10.2

195

1190

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.1

10.2

434

WX882

NOMESCO Finland

High dependency care

2.3

10.2

337

ZXD35

NOMESCO Finland

Usual procedure

2.2

10.2

382

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

10.2

303

2058

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

10.1

442

A10BH05

ATC

linagliptin; oral

1.9

10.1

120

636

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.7

10.0

200

AN1

Coronary angiography

1.6

10.0

241

1560

WX721

NOMESCO Finland

Oxygen concentrator therapy

10.1

10.0

Z94.1

ICD-10 Finland

Heart transplant status

10.1

10.0

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

3.8

9.9

R31

ICD-10 Finland

Unspecified haematuria

1.6

9.9

253

1660

RS220, ,

NOMESCO Finland

3.1

9.9

130

A08

ICPC

Swelling

1.8

9.9

134

741

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.2

9.9

361

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.1

9.9

467

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.5

9.9

255

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.8

9.9

134

742

SPAT1263

SPAT

Sampling

1.3

9.8

1053

8835

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.9

9.8

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

9.8

533

4053

J96.9

ICD-10 Finland

Respiratory failure, unspecified

4.4

9.8

3025

Kela drug reimbursment

Calcium carbonate

4.5

9.8

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

9.8

125

679

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

3.0

9.7

142

J05AB11

ATC

valaciclovir; oral

1.5

9.7

349

2463

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

9.7

102

519

B97.2

ICD-10 Finland

Coronavirus as the cause of diseases classified to other chapters

55.2

9.6

J01EA01

ATC

trimethoprim; systemic

1.4

9.6

560

4303

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.7

9.6

164

971

U08

ICD-10 Finland

Personal history of COVID-19

7.8

9.6

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

9.6

570

4397

D07AC01

ATC

betamethasone; topical

1.3

9.6

904

7457

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

9.5

193

1197

R5110, ,

SPAT

1.6

9.5

199

1244

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

9.5

114

606

C01CA24

ATC

epinephrine; parenteral

1.7

9.5

160

944

A01AB09

ATC

miconazole; local oral

1.7

9.5

187

1151

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

9.1

9.5

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

3.0

9.5

139

M54.5

ICD-10 Finland

Low back pain

1.3

9.4

937

7775

R55

ICD-10 Finland

Syncope and collapse

1.5

9.4

264

1770

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.0

9.3

498

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

2.2

9.3

370

N03AX14

ATC

levetiracetam; systemic

2.2

9.3

357

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

9.3

212

1354

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

4.9

9.3

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

9.2

437

3243

EBA05, ,

SPAT

2.6

9.2

203

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.6

9.2

201

1271

R4130

NOMESCO Finland

Speech therapy

2.2

9.2

333

R95

ICPC

Chron obstructive pulmonary disease

2.3

9.2

308

N06AB10

ATC

escitalopram; oral

1.4

9.1

523

4007

J01FA15

ATC

telithromycin; oral

1.6

9.1

216

1393

A07AA09

ATC

vancomycin; oral

2.9

9.1

142

I50

ICD-10 Finland

Heart failure

2.3

9.1

290

WW300

NOMESCO Finland

Transfer of autologic stem cells

5.0

9.1

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.8

9.1

129

725

3829X

ICD-9 Finland

Suppurative and unspecified otitis media, Unspecified otitis media

11.5

9.1

TK820

NOMESCO Finland

Peritoneal dialysis

4.6

9.1

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

4.0

9.0

M05BA04

ATC

alendronic acid; oral

1.7

9.0

170

1035

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

9.0

J02AC03

ATC

voriconazole; systemic

10.0

9.0

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.3

9.0

279

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

9.0

254

1706

S18

ICPC

Laceration/cut

1.3

9.0

1190

10226

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

9.0

680

5433

RS221, ,

NOMESCO Finland

2.8

9.0

149

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

8.9

479

3630

D07AA02

ATC

hydrocortisone; topical

1.4

8.9

348

2494

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

8.9

119

656

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.0

8.9

128

C09AA02

ATC

enalapril; systemic

1.4

8.9

425

3161

V03AE03

ATC

lanthanum carbonate; oral

4.9

8.8

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

2.6

8.8

190

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

4.7

8.8

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.3

8.8

294

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.0

8.8

447

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

3.0

8.8

129

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

8.8

202

1295

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.8

8.7

151

T82

ICPC

Obesity

1.9

8.7

102

538

B03XA01

ATC

erythropoietin; parenteral

3.7

8.7

E86

ICD-10 Finland

Volume depletion

2.3

8.7

277

GD1AA, ,

SPAT

1.4

8.7

425

3173

205

Kela drug reimbursment

Chronic hypertension

1.3

8.7

577

4522

WX723

NOMESCO Finland

CPAP therapy

1.8

8.6

118

656

J01DC02

ATC

cefuroxime; systemic

1.8

8.6

124

700

3810A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Acute nonsuppurative otitis media

4.8

8.6

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.1

8.6

363

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.1

8.5

110

XF402

NOMESCO Finland

ECG with work load test

1.5

8.5

235

1570

1XC02, ,

NOMESCO Finland

3.8

8.5

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.9

8.5

522

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.6

8.5

182

WX320

NOMESCO Finland

Spinalanesthesy

1.3

8.5

575

4515

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

3.0

8.5

126

XF602

NOMESCO Finland

Bloodpressure monitoring

3.0

8.5

126

3AC01, ,

NOMESCO Finland

3.4

8.5

R06.4

ICD-10 Finland

Hyperventilation

2.9

8.5

137

SPAT1324

SPAT

Screening procedure

0.6

8.5

152

2438

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.3

8.5

274

H26.3

ICD-10 Finland

Drug-induced cataract

4.2

8.4

T74.1

ICD-10 Finland

Physical abuse

2.4

8.4

249

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

8.4

294

2062

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.8

8.4

116

646

P01AB01

ATC

metronidazole; oral, rectal

1.3

8.4

934

7838

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.9

8.4

104

560

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.4

8.4

219

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.0

8.4

476

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

4.7

8.3

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

3.8

8.3

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

3.8

8.3

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

8.3

204

1327

C10AA05

ATC

atorvastatin; oral

1.3

8.3

986

8340

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.2

8.3

302

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.8

8.2

119

673

P29

ICPC

Psychological sympt/compl other

1.6

8.2

208

1363

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

8.2

495

3821

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.5

8.1

192

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

2.5

8.1

204

I45.9

ICD-10 Finland

Conduction disorder, unspecified

3.6

8.1

WPB10

NOMESCO Finland

Making a convalescent care decision

4.8

8.1

L03AA13

ATC

pegfilgrastim; parenteral

1.9

8.1

517

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

33.4

8.1

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

8.1

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.3

8.1

248

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

17.2

8.1

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

17.2

8.1

R07.3

ICD-10 Finland

Other chest pain

1.5

8.1

252

1729

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

8.1

929

7824

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

8.0

173

1091

WX199

NOMESCO Finland

Other local analgesia

2.0

8.0

427

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.9

8.0

490

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

8.0

227

1525

D86.0

ICD-10 Finland

Sarcoidosis of lung

3.0

8.0

109

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.6

8.0

198

1292

N06AX26

ATC

vortioxetine; oral

1.6

8.0

198

1292

48509

ICD-8 Finland

Bronchopneumonia, unspecified

3.2

7.9

D06AX01

ATC

fusidic acid; topical

1.5

7.9

225

1512

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

4.3

7.9

K65.0

ICD-10 Finland

Acute peritonitis

3.0

7.9

115

J01DA08

ATC

[U] cefaclor

1.5

7.9

291

2062

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

4.4

7.9

SPAT1127

SPAT

Enema

4.0

7.9

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

4.6

7.9

B01AC04

ATC

clopidogrel; oral

1.4

7.9

365

2698

R52.2

ICD-10 Finland

Other chronic pain

1.9

7.8

494

L04AX03

ATC

methotrexate; systemic

1.5

7.8

226

1526

WW200, ,

SPAT

0.7

7.8

466

5951

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.2

7.8

310

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.1

7.8

357

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.0

7.8

398

R25.2

ICD-10 Finland

Cramp and spasm

2.2

7.8

278

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

7.7

135

806

H01

ICPC

Ear pain/earache

1.4

7.7

292

2079

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.8

7.7

116

664

PBM09

NOMESCO Finland

Closure of arteriovenous fistula of brachial artery

45.1

7.7

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

7.7

242

1663

M05BX04

ATC

denosumab; parenteral

1.7

7.7

124

725

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.9

7.7

100

548

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

7.7

271

1906

A10AB04

ATC

insulin lispro; parenteral

2.0

7.6

421

K02.1

ICD-10 Finland

Caries of dentine

1.2

7.6

1613

14516

N05AH02

ATC

clozapine; systemic

2.4

7.6

223

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

3.7

7.6

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

7.6

137

826

N20.0

ICD-10 Finland

Calculus of kidney

2.3

7.6

236

A07EC01

ATC

sulfasalazine; oral, rectal

1.6

7.6

180

1163

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

7.6

202

1340

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.8

7.6

110

624

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

7.5

549

4355

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

7.5

330

2418

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.2

7.5

257

F05.9

ICD-10 Finland

Delirium, unspecified

2.3

7.4

238

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.4

7.4

N06AA09

ATC

amitriptyline; systemic

1.6

7.4

189

1242

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.7

7.4

145

894

R06AX27

ATC

desloratadine; oral

1.3

7.4

710

5837

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.4

7.4

KH1AD

NOMESCO Finland

CT of urinary organs

1.9

7.4

462

C09CA06

ATC

candesartan; oral

1.3

7.3

560

4465

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

4.0

7.3

S09.9

ICD-10 Finland

Unspecified injury of head

2.5

7.3

184

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.9

7.3

470

XA800

NOMESCO Finland

Neuropsychological investigation

1.8

7.3

110

630

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

7.3

369

2767

A10BH01

ATC

sitagliptin; oral

1.5

7.3

207

1393

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.2

7.3

273

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

7.3

225

1542

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.7

7.2

138

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

7.2

144

891

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

7.2

192

1273

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.0

7.2

409

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

7.3

7.2

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.7

7.2

120

709

SPAT1088

SPAT

Blood transfusion

4.5

7.2

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.0

7.2

355

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

7.1

531

4218

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

7.1

163

1044

C10AA01

ATC

simvastatin; oral

1.3

7.1

892

7564

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

7.1

180

1180

GX1P5

NOMESCO Finland

Nocturnal CO2 monitoring

20.1

7.1

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

7.1

194

1294

1240

FHL

Bronchoscopy

3.2

7.1

C01DA14

ATC

isosorbide mononitrate; oral

1.4

7.1

322

2370

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

7.1

1431

12776

E66.9

ICD-10 Finland

Obesity, unspecified

1.9

7.1

454

SPAT1260

SPAT

Consultation of another employee

1.4

7.1

398

3034

J16.8

ICD-10 Finland

Pneumonia due to other specified infectious organisms

12.0

7.1

K08.3

ICD-10 Finland

Retained dental root

1.5

7.1

187

1239

B02.9

ICD-10 Finland

Zoster without complication

1.6

7.1

152

960

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

2.9

7.1

112

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

7.0

229

1587

D07AB08

ATC

desonide; topical

1.5

7.0

248

1746

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

7.0

421

CKC15

NOMESCO Finland

Panretinal photocoagulation

3.3

7.0

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

7.0

202

1366

N06AB06

ATC

sertraline; oral

1.4

6.9

278

2002

T89

ICPC

Diabetes insulin dependent

1.7

6.9

109

633

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

6.9

647

5294

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

6.9

139

863

L12

ICPC

Hand/finger symptom/complaint

1.3

6.9

421

3249

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

6.9

229

1592

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

4.0

6.9

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

6.9

375

2845

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.3

6.9

221

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

6.9

142

888

A40.1

ICD-10 Finland

Sepsis due to streptococcus, group B

8.3

6.8

J43.2

ICD-10 Finland

Centrilobular emphysema

6.7

6.8

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

10.9

6.8

WW400

NOMESCO Finland

Plasmaferesis

9.3

6.8

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.1

6.8

301

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

6.8

101

578

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

2.3

6.8

210

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

6.7

113

669

KBV10

NOMESCO Finland

Removal of stent from ureter

3.2

6.7

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.5

6.7

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.2

6.7

ED1AA

NOMESCO Finland

Mandibular X-ray examination

3.3

6.7

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

6.7

138

863

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

6.7

161

1045

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.6

6.7

139

871

M10

ICD-10 Finland

Gout

1.7

6.7

106

618

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

6.6

636

5218

RD210, ,

NOMESCO Finland

2.4

6.6

193

U09

ICD-10 Finland

Post COVID-19 condition

2.9

6.6

105

D10

ICPC

Vomiting

1.6

6.6

153

984

XF622

NOMESCO Finland

Measurement of minute volume of heart

5.9

6.6

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

2.5

6.6

163

R25.1

ICD-10 Finland

Tremor, unspecified

1.9

6.6

380

A01

ICPC

Pain general/multiple sites

1.5

6.6

231

1623

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.2

6.5

226

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.2

6.5

239

J01CA08

ATC

pivmecillinam; oral

1.2

6.5

832

7057

D07AC13

ATC

mometasone; topical

1.3

6.5

676

5599

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

2.6

6.5

146

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.6

6.5

146

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

1.8

6.5

460

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.9

6.5

410

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

6.5

132

822

EBA00

NOMESCO Finland

Extraction of tooth

1.2

6.5

960

8274

A91

ICPC

Abnormal result investigation NOS

1.6

6.5

133

830

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

6.5

960

8275

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

6.5

235

1661

A29

ICPC

General symptom/complaint other

1.4

6.5

305

2259

N02AA01

ATC

morphine; systemic, rectal

2.3

6.5

189

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

2.9

6.5

101

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.3

6.5

208

4451

FHL

Guitar cutting

1.8

6.5

483

U71

ICPC

Cystitis/urinary infection other

1.6

6.4

141

895

Z00.8

ICD-10 Finland

Other general examinations

1.5

6.4

190

1290

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.2

6.4

241

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.8

6.4

558

G04CA02

ATC

tamsulosin; oral

1.3

6.4

558

4525

U14

ICPC

Kidney symptom/complaint

2.4

6.4

172

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

2.6

6.4

142

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.1

6.4

275

N03AG01

ATC

valproic acid; systemic, rectal

1.6

6.4

141

898

WX202

NOMESCO Finland

Supraclavicular plexus blockade

2.5

6.3

154

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.0

6.3

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

6.3

207

1435

L01XX52

ATC

venetoclax; oral

8.2

6.3

1518, ,

Kela drug reimbursment

8.2

6.3

399

Kela drug reimbursment

Venetoclax

8.2

6.3

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

2.7

6.3

125

4659X

ICD-9 Finland

Acute upper respiratory infections of multiple or unspecified sites, Unspecified site

2.0

6.3

296

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

11.0

6.3

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

6.3

287

2115

XX9XE

NOMESCO Finland

Other ultrasound examination

3.2

6.3

SPAT1107

SPAT

Extensive external surface anaesthesia of skin with cream or gel

9.3

6.3

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

9.3

6.3

5AB14, ,

NOMESCO Finland

9.3

6.3

N05BB01

ATC

hydroxyzine; systemic

1.6

6.3

138

877

WX290, ,

SPAT

1.8

6.3

495

H60

ICD-10 Finland

Otitis externa

1.6

6.3

134

846

U13

ICPC

Bladder symptom/complaint other

2.0

6.3

345

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

18.0

6.3

UJD02

NOMESCO Finland

Gastroscopy

1.7

6.3

101

592

AK1

HTX (heart transplant)

+∞

6.3

48000, ,

ICD-8 Finland

+∞

6.3

JN6AD

NOMESCO Finland

CT of torso and neck

2.4

6.2

180

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

2.1

6.2

284

A98

ICPC

Health maint/preventive medicine

1.5

6.2

2819

27365

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.0

6.2

339

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

6.2

167

1112

E87.6

ICD-10 Finland

Hypokalaemia

1.9

6.2

410

S80.8

ICD-10 Finland

Other superficial injuries of lower leg

3.7

6.2

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

3.1

6.2

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

6.2

319

OAB50, ,

SPAT

1.5

6.2

188

1285

Z76

ICD-10 Finland

Persons encountering health services in other circumstances

2.0

6.2

292

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

3.1

6.2

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

5.3

6.1

N03AX18

ATC

lacosamide; systemic

3.2

6.1

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

5.7

6.1

A87.9

ICD-10 Finland

Viral meningitis, unspecified

3.4

6.1

A99

ICPC

Disease/condition unspecnature/site

1.4

6.1

247

1782

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

7.7

6.1

L14

ICPC

Leg/thigh symptom/complaint

1.5

6.1

185

1263

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

6.1

312

2344

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.8

6.1

478

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

12.5

6.1

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

6.1

242

1742

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

3.0

6.1

LX2A3, ,

SPAT

0.2

6.1

329

GD1CQ

NOMESCO Finland

Lung circulation SPECT with low dose CT

8.6

6.0

GBB00

NOMESCO Finland

Tracheostomy

2.8

6.0

105

A49

ICD-10 Finland

Bacterial infection of unspecified site

6.7

6.0

XG430

NOMESCO Finland

Spiroegometry

6.7

6.0

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.5

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

986

2839

4.68

317.54

2.7

1.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

571

808

8.49

307.65

3.2

2.9

4.78

3.48

g/l

41.72

566

771

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1026

2987

4.69

307.65

2.7

1.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1642

5531

5.33

307.65

3.6

1.8

1.38

1.18

mg/l

1.30

1463

4167

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1310

4009

5.01

307.65

3.0

1.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

580

943

7.38

307.65

2.7

1.9

1.44

2.34

ug/l

0.68

540

833

(3023368) Bacteria identified in Blood by Culture

1856

6743

5.56

307.65

8.0

4.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1207

4205

4.12

297.88

5.7

3.5

0.82

mmol/l

0.11

1175

3992

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

962

2939

4.34

282.80

6.1

4.4

264.24

246.25

u/l

2.64

943

2792

(3022096) Basophils/Leukocytes in Blood

2139

12066

3.66

233.92

12.4

6.6

0.51

0.68

34.99

2097

11334

(3019069) Monocytes/Leukocytes in Blood

2137

12092

3.64

231.53

12.5

6.6

8.49

8.87

6.91

2097

11371

(3006504) Eosinophils/Leukocytes in Blood

2135

12074

3.64

231.51

12.4

6.5

2.16

2.82

37.53

2094

11345

(3014111) Lactate [Moles/volume] in Serum or Plasma

766

2281

4.16

228.22

18.8

8.6

1.30

1.36

mmol/l

0.73

757

2237

(3018010) Neutrophils/Leukocytes in Blood

2126

12199

3.52

220.53

11.8

6.4

61.39

56.86

48.69

2100

11687

(3002030) Lymphocytes/Leukocytes in Blood

2151

12446

3.55

219.74

12.5

6.5

24.14

28.26

45.62

2116

11829

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

367

601

6.81

218.46

2.5

1.6

—

(3001604) Monocytes [#/volume] in Blood

2213

13177

3.56

212.47

11.7

6.3

0.61

0.58

e9/l

4.65

1898

11352

(3006315) Basophils [#/volume] in Blood

2214

13197

3.56

211.96

11.8

6.4

0.04

e9/l

3.85

1899

11376

(3000991) Gas panel - Venous blood

733

2223

4.04

211.49

21.5

9.8

—

(3019977) pH of Arterial blood

840

2856

3.69

204.43

18.2

8.6

7.42

7.41

2.81

386

1586

(3003396) Base excess in Arterial blood by calculation

835

2834

3.69

203.67

18.2

8.5

1.03

0.74

mmol/l

1.13

719

2311

(3019198) Lymphocytes [#/volume] in Blood

2228

13507

3.49

203.55

11.8

6.4

1.97

1.93

e9/l

0.21

1943

11926

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

837

2853

3.68

202.74

18.7

8.6

5.03

5.08

kpa

0.58

812

2756

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

565

1454

4.55

202.70

22.7

11.0

24.68

24.10

mmol/l

3.67

556

1430

(3027801) Oxygen [Partial pressure] in Arterial blood

836

2853

3.67

202.05

18.7

8.5

10.63

12.59

kpa

27.50

807

2755

(3013115) Eosinophils [#/volume] in Blood

2233

13602

3.48

201.37

12.6

6.6

0.17

0.19

e9/l

7.90

1937

11910

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

353

624

6.28

194.24

2.6

1.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

729

2343

3.79

191.81

14.2

7.8

10.13

9.56

mmol/l

1.16

714

2261

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

290

430

7.36

188.81

2.3

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

326

561

6.39

184.05

4.1

2.3

127.05

130.87

g/l

1.53

262

463

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

129

25.38

183.51

1.4

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

313

524

6.55

181.55

2.3

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1118

4826

3.09

180.97

5.6

3.7

325.48

454.24

ng/l

0.68

916

3639

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

114

33.81

178.53

1.4

1.1

99.11

86.26

ng/l

0.07

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

529

1421

4.30

178.16

6.7

4.0

2.20

1.65

mmol/l

3.09

441

1040

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

530

1442

4.25

175.32

2.2

1.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2286

14729

3.29

174.70

18.2

9.4

4.38

4.07

e9/l

8.31

1998

12781

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

233

302

8.28

170.29

2.6

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

266

403

7.14

169.47

2.6

1.7

—

(3016502) Oxygen saturation in Arterial blood

735

2568

3.46

168.13

20.4

8.9

93.88

95.76

9.75

713

2491

(1616796) Gas panel - Central venous blood

308

552

6.10

166.48

6.8

3.7

—

(3009343) pH of Capillary blood

555

1622

3.97

165.80

7.1

4.0

7.43

7.41

5.92

528

1347

(3003458) Phosphate [Moles/volume] in Serum or Plasma

858

3378

3.15

160.24

12.0

6.5

1.07

1.04

mmol/l

1.89

836

3152

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

360

772

5.16

159.75

3.7

3.3

0.32

0.35

iu/ml

0.81

179

419

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

235

336

7.50

157.63

2.3

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

1378

7111

2.73

154.21

5.4

3.2

0.42

0.40

e6/l

0.21

1062

5185

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2445

16939

3.35

153.53

4.0

3.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

683

2417

3.36

151.63

21.6

9.3

121.25

123.19

g/l

1.40

670

2367

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

168

177

9.99

144.14

2.3

1.6

—

(3033658) Prothrombin time (PT) actual/Normal

1268

6465

2.66

142.73

7.6

4.2

90.13

89.16

0.70

1253

6332

(3002032) Base excess in Venous blood by calculation

685

2515

3.23

142.30

6.9

4.2

1.80

1.72

mmol/l

0.25

623

2150

(3002582) Erythrocytes [#/volume] in Urine

1494

8255

2.61

142.29

5.7

3.3

31.45

84.58

e6/l

3.62

1184

6290

(3021589) Normoblasts [#/volume] in Blood

1861

11466

2.63

140.37

23.5

11.0

0.00

e9/l

0.64

1475

9363

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

209

299

7.44

139.90

2.6

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

252

439

6.17

139.75

2.2

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

444

1244

4.01

139.48

1.6

1.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2037

13137

2.70

139.38

12.5

6.4

10.33

11.95

umol/l

11.48

1978

12549

(3012544) pH of Venous blood

696

2612

3.16

139.01

7.0

4.2

7.38

0.19

449

1526

(3021447) Carbon dioxide [Partial pressure] in Venous blood

690

2583

3.17

138.34

6.9

4.1

5.83

5.82

kpa

0.03

678

2509

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1942

12331

2.62

135.57

19.2

7.4

1.20

1.21

mmol/l

21.16

1746

10660

(3018095) Leukocytes [#/volume] in Urine

1628

9532

2.54

134.86

6.8

3.9

117.59

97.20

e6/l

0.24

1203

6670

(36304419) Bacteria [Presence] in Urine

1292

6829

2.56

132.65

5.2

3.1

7.75

98.30

estimate

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1791

11051

2.53

131.15

17.7

6.8

1.19

1.21

mmol/l

21.34

1718

10247

(3014007) Fractional oxyhemoglobin in Arterial blood

509

1652

3.50

128.13

26.5

10.8

92.94

94.10

4.84

509

1644

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

278

575

5.22

127.89

10.6

5.5

1785.04

362.72

iu/ml

1.16

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1926

12430

2.52

125.76

4.7

3.1

281.90

120.78

ug/l

38.39

1863

11691

(3018677) aPTT in Platelet poor plasma by Coagulation assay

862

3915

2.68

118.76

3.8

2.2

30.47

29.64

2.87

846

3809

(3013826) Glucose [Moles/volume] in Serum or Plasma

2163

14974

2.58

117.51

14.7

5.1

6.95

6.68

mmol/l

6.78

2106

14146

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

872

4053

2.62

113.99

4.3

3.1

2.32

2.17

e6/l

0.18

455

1963

(3005719) IgG [Mass/volume] in Serum or Plasma

557

2052

3.10

112.91

5.2

2.9

9.47

10.71

g/l

7.97

534

1894

(3024561) Albumin [Mass/volume] in Serum or Plasma

1750

11139

2.36

112.81

8.8

5.2

34.12

36.02

g/l

30.34

1679

10475

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

132

142

9.68

111.31

2.3

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

227

450

5.37

109.25

4.9

3.2

283.79

1454.45

u/ml

0.88

(3018418) pH of Serum or Plasma

1287

7312

2.33

106.57

8.6

4.2

7.40

1.91

965

5229

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

122

129

9.81

104.15

2.5

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

138

172

8.36

103.68

2.6

1.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

900

4421

2.48

103.12

4.3

2.9

0.92

0.99

e6/l

0.27

479

2331

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1234

6969

2.31

102.71

4.8

3.1

1809.87

1351.32

ng/l

2.29

1105

5911

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

118

125

9.78

100.58

2.5

1.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

781

3642

2.54

99.59

4.3

2.7

21.89

23.30

2.22

743

3413

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

281

718

4.21

99.00

3.2

2.7

—

(3042936) Bacteria identified in Isolate by Culture

769

3586

2.54

97.85

2.9

2.1

—

(3012501) Base excess in Blood by calculation

230

508

4.82

97.47

7.2

4.3

2.43

2.53

mmol/l

0.19

164

330

(3022948) Iron [Moles/volume] in Serum or Plasma

858

4253

2.42

95.23

4.3

2.6

11.96

13.48

umol/l

8.47

815

3987

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

213

453

4.98

94.38

2.0

1.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

815

3963

2.45

94.26

4.3

2.6

2.24

2.32

g/l

3.69

773

3686

(3032080) INR in Blood by Coagulation assay

1712

11304

2.19

94.16

20.0

14.4

1.24

1.25

inr

0.34

1495

9446

(3000850) Epithelial cells [#/volume] in Urine

1042

5675

2.28

92.49

4.8

2.6

5.52

e6/l

0.00

976

5161

(3024354) Oxygen [Partial pressure] in Venous blood

541

2174

2.81

92.33

5.7

3.5

4.99

4.57

kpa

2.91

528

2112

(3017181) Myelocytes/Leukocytes in Blood

555

2271

2.77

91.42

6.9

4.6

0.97

0.89

0.34

309

670

(3026782) Osmolality of Urine

928

4850

2.32

90.51

4.7

2.9

517.92

541.22

mosm/kgh2o

2.76

849

4256

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

467

1758

2.96

89.78

2.0

1.7

—

(3036489) Thrombin time

334

1033

3.51

89.16

2.9

2.3

21.40

20.85

0.98

314

929

(3015377) Calcium [Moles/volume] in Serum or Plasma

1369

8430

2.14

88.27

4.8

3.4

2.33

2.35

mmol/l

10.75

1300

7726

(44790049) Parainfluenza type 3 nucleic acid detection

170

315

5.66

87.87

2.5

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

170

315

5.66

87.87

2.5

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

170

315

5.66

87.87

2.5

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

170

315

5.66

87.87

2.5

1.4

—

(3021440) Promyelocytes/Leukocytes in Blood

530

2177

2.74

86.29

7.0

4.6

0.08

0.11

0.70

285

578

(3027945) Reticulocytes/Erythrocytes in Blood

641

2922

2.52

84.21

4.8

2.8

1.88

1.75

2.52

594

2631

(3002179) Metamyelocytes/Leukocytes in Blood

523

2163

2.72

83.84

6.6

4.4

0.70

0.67

0.17

292

633

(3028026) IgM [Mass/volume] in Serum or Plasma

428

1603

2.95

82.67

3.3

2.0

1.32

1.38

g/l

0.20

398

1488

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2456

19282

2.48

82.08

16.1

7.9

80.98

78.47

u/l

2.11

2403

18356

(3023419) Bacteria identified in Sputum by Culture

150

265

5.90

81.48

3.0

2.1

—

(3004809) Band form neutrophils/Leukocytes in Blood

182

387

4.94

80.51

5.0

3.7

1.46

1.44

0.04

170

354

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

881

4739

2.21

78.28

3.1

2.9

2.46

2.44

mmol/l

4.23

830

4272

(3040151) Glucose [Moles/volume] in Capillary blood

146

267

5.70

76.45

51.5

6.4

7.11

7.12

mmol/l

0.02

137

230

(3007853) Bacteria identified in Skin by Aerobe culture

633

3023

2.38

74.13

2.2

1.7

—

(3026250) Tacrolimus [Mass/volume] in Blood

100

128

8.05

73.36

52.2

41.4

7.46

7.19

ug/l

0.53

119

(3031040) Bacteria [#/volume] in Urine by Automated count

2158

16376

2.12

73.19

7.1

4.4

225.16

1500.25

e6/l

2.50

229

(3025159) Blasts/Leukocytes in Blood

509

2212

2.57

73.10

6.9

4.8

0.03

0.12

1.98

261

548

(3023520) Reticulocytes [#/volume] in Blood

509

2216

2.56

72.80

4.7

2.8

71.26

69.13

e9/l

0.67

349

1620

(3026008) Bacteria identified in Urine by Culture

1162

7131

2.02

71.56

4.4

3.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

328

1151

3.08

70.65

2.5

1.9

1.57

1.50

g/l

0.61

294

1005

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

121

203

6.17

69.23

3.2

3.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

109

173

6.50

65.86

1.4

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2222

17334

2.07

65.85

7.1

4.3

—

3.55

—

(3044640) Blood type and Crossmatch panel - Blood

1268

8270

1.92

63.34

3.7

2.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

122

228

5.53

62.35

2.4

1.8

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1326

8833

1.90

61.58

4.5

3.3

41.73

35.44

u/l

0.36

1268

8346

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

520

2457

2.35

61.38

3.4

2.6

37.38

60.89

u/l

0.63

450

2076

(46235355) HIV 1 and 2 tests - Meaningful Use set

974

5873

1.97

60.92

2.3

2.0

—

(40758558) Short blood count panel - Blood

1184

7622

1.91

60.91

10.4

6.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

201

570

3.71

60.65

1.8

1.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

452

2020

2.46

60.38

4.6

2.8

64.80

66.63

g/l

5.11

424

1876

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1181

7620

1.90

60.14

3.1

2.2

338.95

230.47

u/l

0.94

1138

7235

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

126

251

5.20

59.99

2.4

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

224

688

3.44

59.87

2.2

1.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

171

442

4.04

58.84

1.5

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

171

442

4.04

58.84

1.5

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

201

582

3.63

58.79

1.8

1.5

13.33

17.68

u/ml

—

(3022313) Gas panel - Capillary blood

307

1157

2.84

57.77

7.1

4.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

373

1569

2.57

56.49

6.1

3.5

125.36

130.34

g/l

3.77

362

1525

(3000494) Fungus identified in Specimen by Culture

592

3062

2.16

55.65

2.1

1.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1058

6722

1.88

55.43

3.0

2.3

2.95

2.73

mg/l

1.92

941

5807

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1354

9293

1.83

55.35

6.4

3.6

255.79

58.37

ng/l

0.74

1004

6284

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

102

181

5.80

55.06

2.2

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

102

181

5.80

55.06

2.2

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

102

181

5.80

55.06

2.2

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1045

6658

1.87

53.95

4.9

2.7

358.71

345.66

umol/l

3.31

963

5937

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

184

533

3.61

53.73

1.8

1.5

150.18

148.51

au/ml

0.07

153

(3037692) Legionella sp identified in Specimen by Organism specific culture

9.58

53.41

1.8

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

196

600

3.42

52.57

1.4

1.3

250.80

256.58

u/ml

0.10

141

375

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

218

719

3.19

51.81

5.5

3.5

5.01

3.37

ratio

0.42

113

417

(3036481) Cortisol [Moles/volume] in Serum or Plasma

500

2486

2.21

51.57

2.6

2.2

340.59

382.03

nmol/l

4.35

470

2307

(3017143) Hepatitis C virus Ab [Presence] in Serum

636

3483

2.05

50.92

2.1

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

200

633

3.31

50.85

1.4

1.3

—

99.21

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

503

2527

2.19

50.48

5.8

3.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

985

6282

1.84

49.85

3.6

2.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

279

1085

2.73

49.23

7.8

3.4

25.20

mmol/l

0.00

272

1039

(3017354) Segmented neutrophils/Leukocytes in Blood

114

248

4.74

48.93

4.2

3.7

58.99

57.16

0.32

106

220

(3042733) HLA Ab [Presence] in Serum

7.65

48.85

4.9

4.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

242

880

2.90

48.44

3.1

2.2

1383.24

425.99

ug/l

0.49

235

836

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

212

724

3.07

47.42

1.6

1.3

—

(3011412) CD3 cells [#/volume] in Blood

114

256

4.59

47.07

2.6

2.3

1023.82

1264.30

e6/l

2.43

101

222

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1544

11360

1.74

47.01

3.2

2.4

72.86

75.61

nmol/l

3.55

1442

10399

(40760892) CBC W Ordered Manual Differential panel - Blood

944

6037

1.82

46.75

8.5

4.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

405

1918

2.28

46.72

8.8

4.0

1.21

1.23

mmol/l

5.54

386

1650

(3009445) Proteinase 3 Ab [Units/volume] in Serum

271

1076

2.67

45.82

2.1

1.6

14.07

16.29

iu/ml

0.12

(3021879) Hepatitis B virus core Ab [Presence] in Serum

458

2310

2.16

45.15

1.6

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

197

5.00

44.15

2.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

221

804

2.89

44.13

6.3

3.7

48.96

74.26

mg/l

0.61

173

685

(3034860) Kappa light chains.free [Mass/volume] in Serum

221

805

2.88

44.02

6.3

3.7

53.88

60.74

mg/l

0.31

171

686

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

107

6.67

43.82

2.2

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

107

6.67

43.82

2.2

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

107

6.67

43.82

2.2

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

107

6.67

43.82

2.2

1.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1592

11964

1.70

43.55

4.0

2.8

—

estimate

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

780

4796

1.85

43.34

2.1

1.7

—

(3014051) Protein [Presence] in Urine by Test strip

1091

7414

1.74

43.09

4.1

2.8

0.00

0.04

1.02

141

(3015736) pH of Urine

1483

10956

1.70

43.06

4.8

3.3

6.18

6.21

0.65

802

6242

(3048929) Epstein Barr virus Ab [Presence] in Serum

256

1028

2.63

42.23

1.4

1.3

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

370

1758

2.26

42.13

1.7

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

219

815

2.82

41.89

3.3

1.8

—

(3042631) Mycobacterium sp identified in Specimen

113

277

4.20

41.70

3.0

2.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

176

581

3.16

41.66

1.7

1.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

236

918

2.70

41.46

1.4

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

856

5479

1.79

41.32

2.5

1.5

2.34

2.39

g/l

0.23

598

3476

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

243

969

2.64

40.63

3.4

2.4

4.14

4.19

g/l

0.42

231

893

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

243

969

2.64

40.63

3.4

2.4

7.57

7.36

g/l

1.05

230

893

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

243

969

2.64

40.63

3.4

2.4

3.61

3.72

g/l

0.68

231

893

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1469

10933

1.67

40.61

2.4

2.1

91.16

95.71

pmol/l

3.62

822

5976

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

231

901

2.69

40.35

3.7

1.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

220

842

2.74

39.87

3.1

2.5

9.84

10.40

g/l

0.98

206

763

(3042111) Morphology [Interpretation] in Bone marrow Narrative

141

419

3.48

39.53

1.8

1.6

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2234

18644

1.77

39.50

7.0

4.1

15.73

10.98

mm/h

28.68

2162

17482

(3009261) Glucose [Presence] in Urine by Test strip

1753

13727

1.66

39.18

5.9

3.7

0.01

0.12

estimate

0.49

431

2681

(3021601) Nitrite [Presence] in Urine by Test strip

1730

13518

1.66

38.84

5.9

3.6

0.00

estimate

0.80

451

2828

(21494814) CD8 cells/Lymphocytes in Specimen

6.64

38.72

2.2

2.0

32.85

30.06

0.53

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

529

2964

1.95

38.64

4.4

2.9

7.44

8.03

umol/l

0.34

460

2617

(3035350) Ketones [Presence] in Urine by Test strip

1741

13669

1.65

37.96

5.9

3.7

3.84

4.84

estimate

0.09

456

2870

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

228

914

2.62

37.66

3.5

2.5

3.07

2.95

g/l

0.88

216

839

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2787

25155

2.44

37.57

39.5

14.6

30.99

23.93

mg/l

26.47

2623

20561

(3005322) IgE [Units/volume] in Serum or Plasma

343

1653

2.21

37.54

1.6

1.3

166.90

263.21

u/ml

0.95

317

1527

(40768446) Kidney Pathology biopsy report

115

5.94

37.44

2.1

1.7

—

(3017569) Oxygen content in Arterial blood

132

5.48

36.48

1.7

2.6

15.50

16.39

1.18

132

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

213

850

2.62

35.48

6.9

4.7

1.85

1.49

mg/l

6.24

203

781

(3024980) IgG subclass 4 [Mass/volume] in Serum

138

434

3.28

35.37

1.5

1.8

0.56

0.85

g/l

3.40

351

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

116

327

3.65

35.22

7.8

6.2

11.75

11.64

mg/l

0.08

104

306

(4062490) Immunoglobulin typing, IgG

246

4.08

35.05

1.2

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

116

5.70

34.89

38.4

27.0

127.53

119.14

ug/l

0.36

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

385

2004

2.06

34.37

3.1

2.3

11.30

7.31

ug/l

1.54

334

1792

(3021960) Folate [Moles/volume] in Serum or Plasma

1007

7017

1.65

34.35

2.0

1.7

19.97

19.95

nmol/l

0.01

920

6015

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1117

7990

1.63

34.33

4.0

2.6

53.84

70.25

u/l

0.98

1047

7423

(3024139) IgG subclass 3 [Mass/volume] in Serum

247

4.02

34.03

1.2

1.3

0.39

g/l

0.02

180

(3027135) IgG subclass 1 [Mass/volume] in Serum

247

4.02

34.03

1.2

1.3

6.32

6.72

g/l

0.36

182

(3037522) Nuclear Ab [Titer] in Serum

591

3565

1.82

33.89

1.6

1.4

513.49

491.14

titre

0.11

129

729

(3028192) IgG subclass 2 [Mass/volume] in Serum

248

4.01

33.84

1.2

1.3

2.70

3.04

g/l

0.77

182

(3035715) Granulocytes [#/volume] in Blood

139

452

3.18

33.72

4.2

3.6

4.11

4.08

e9/l

0.06

139

452

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

208

847

2.56

33.22

3.7

2.5

0.96

1.11

g/l

0.24

175

733

(3045142) Bone marrow Pathology biopsy report

106

293

3.71

33.13

1.5

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

217

4.20

33.10

1.4

1.3

85.80

84.18

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

357

1847

2.06

32.31

4.3

2.8

236.63

187.20

ng/l

1.12

331

1690

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

100

271

3.78

32.16

1.2

1.1

—

(3035933) Granulocytes/Leukocytes in Blood

159

576

2.86

31.91

4.7

3.4

58.38

57.96

0.15

159

576

(3008757) Leukocyte morphology finding [Identifier] in Blood

239

3.94

31.41

5.5

4.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

309

1536

2.13

31.06

10.7

7.1

24.51

24.34

mmol/l

0.29

295

1475

(3011397) Hemoglobin [Presence] in Urine by Test strip

883

6098

1.63

30.46

4.6

3.5

0.00

0.14

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

181

724

2.60

29.96

2.5

2.4

0.04

0.02

g/l

0.37

164

653

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

433

2458

1.89

29.83

2.6

2.3

0.22

0.21

g/l

0.29

400

2300

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

222

979

2.37

29.80

1.5

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

347

1836

2.01

29.40

7.2

4.2

124.17

89.30

ng/l

4.39

302

1615

(3004451) EKG impression Narrative

144

4.74

29.22

1.5

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

125

417

3.08

29.05

1.2

1.1

0.42

0.86

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2437

21438

1.72

29.01

43.3

18.1

13.92

13.52

32.49

2430

21149

(3024932) HLA-DR beta [Type]

6.11

28.91

1.1

—

(3024471) HLA-A [Type]

6.04

28.57

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

109

339

3.30

28.46

2.4

2.5

14.54

42.00

iu/ml

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

121

5.04

28.19

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

141

513

2.83

28.07

1.8

1.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.67

27.87

1.1

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2652

23991

1.88

27.61

35.1

14.2

82.48

84.33

ml/min/173m2

3.35

2481

22049

(3019550) Sodium [Moles/volume] in Serum or Plasma

2758

25293

2.07

27.37

44.2

17.2

139.21

139.66

mmol/l

19.13

2733

24809

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

105

328

3.28

27.23

1.4

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

172

706

2.52

26.98

2.6

2.4

0.00

g/l

-0.00

155

620

(3000012) Reticulocyte production index

108

350

3.16

26.37

3.3

2.2

0.91

0.89

0.07

239

(3020682) Albumin/Creatinine [Ratio] in Urine

1079

8017

1.54

26.33

5.6

4.3

17.06

11.45

mg/mmol

1.08

732

5146

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2106

18030

1.56

26.27

4.5

3.3

53.55

47.15

u/l

2.78

2018

17089

(3019309) Folate [Moles/volume] in Red Blood Cells

613

3986

1.68

26.20

2.0

1.7

1171.23

1158.34

nmol/l

0.12

485

3047

(40761536) Microorganisms panel - Urine sediment

374

2109

1.88

26.11

7.4

3.8

—

(3037756) Immunofixation for Serum or Plasma

135

499

2.79

26.09

2.4

1.7

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

126

4.76

25.94

1.3

1.2

118.71

91.10

u/l

0.91

110

(3024891) Influenza virus A+B Ag [Presence] in Specimen

173

726

2.47

25.88

1.2

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2757

25360

2.03

25.88

44.9

17.3

3.97

mmol/l

0.10

2730

24823

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

176

4.11

25.87

1.6

1.2

4.83

2.47

u/ml

0.49

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

161

655

2.54

25.73

2.5

0.00

g/l

-0.00

155

619

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

219

3.73

25.40

1.3

1.2

66.69

62.14

u/l

0.22

197

(3008536) Aspergillus sp Ab [Presence] in Serum

8.33

25.25

2.4

2.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

170

720

2.44

24.93

1.4

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

214

1012

2.20

24.29

8.7

5.6

0.81

0.88

2.25

209

957

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

188

3.84

23.65

2.4

2.3

478.43

534.45

e6/l

0.47

151

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

119

434

2.81

23.60

1.5

1.2

465.71

390.00

titre

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

5.23

23.15

3.7

4.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

290

3.20

22.87

1.7

1.5

353.29

31.94

g/l

0.49

260

(4035726) Immunohistochemistry procedure

356

2058

1.83

22.83

1.7

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

160

687

2.40

22.77

2.4

2.2

11.21

11.39

mg/l

0.10

152

643

(3009508) Creatinine [Moles/volume] in Urine

1139

8781

1.48

22.27

4.6

3.5

7.56

8.03

mmol/l

2.56

990

7511

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

104

365

2.92

22.15

1.3

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

7.34

22.05

2.9

3.7

42.38

21.60

mg/l

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

123

4.45

21.98

1.3

1.2

41.80

19.44

u/l

2.10

106

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

198

3.65

21.97

2.5

2.2

0.64

0.77

e9/l

1.11

191

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

222

1114

2.07

21.60

8.5

5.3

1.53

1.64

1.15

216

1052

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

115

432

2.73

21.58

1.5

1.2

2.23

4.21

u/ml

1.46

158

(3012516) Albumin [Mass/volume] in Urine

1036

7887

1.48

21.36

4.6

3.6

85.36

53.42

mg/l

2.27

732

5183

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

268

3.20

21.09

1.2

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

219

1115

2.04

20.48

2.4

2.0

36.95

39.70

u/l

1.10

199

1002

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2547

23203

1.63

20.41

6.0

5.1

1.85

1.88

mu/l

0.59

2413

21617

(3014148) Varicella zoster virus Ab [Titer] in Serum

109

411

2.71

20.32

1.1

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

190

3.58

20.25

2.6

2.4

193.52

212.38

e6/l

0.33

161

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

5.12

20.24

2.6

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

5.12

20.24

2.6

2.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

181

3.65

20.18

1.6

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

32.76

20.18

1.6

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

5.06

19.97

2.6

2.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

170

3.70

19.69

2.5

2.7

35.19

42.89

1.57

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

110

4.42

19.41

6.4

3.6

0.98

1.19

0.35

110

(3023183) Ammonium ion [Moles/volume] in Plasma

136

586

2.38

19.22

4.1

3.0

31.64

35.13

umol/l

0.92

127

536

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

142

3.93

19.03

1.6

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

142

3.93

19.03

1.6

1.7

—

(3012441) Differential panel - Pleural fluid

229

3.24

18.88

1.7

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

15.94

18.78

2.5

2.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

7.35

18.65

1.7

1.5

—

(40768806) Pleura Pathology biopsy report

216

3.29

18.59

1.7

1.6

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

334

2015

1.74

18.38

4.2

2.4

0.40

0.42

e6/l

0.07

326

1919

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

193

3.42

18.35

1.6

1.4

704.25

368.98

u/l

0.41

188

(4268621) Lupus anticoagulant assay

308

2.88

18.28

2.6

2.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

180

889

2.09

18.26

1.7

1.6

0.24

0.27

iu/ml

0.05

140

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

5.98

18.23

2.4

1.3

96.66

91.43

0.32

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

138

3.89

18.13

1.5

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

108

432

2.56

17.92

1.5

1.2

3.56

4.71

u/ml

0.60

205

(3002523) Influenza virus A Ag [Presence] in Specimen

128

557

2.36

17.71

1.2

1.1

—

(3047181) Lactate [Moles/volume] in Blood

155

735

2.17

17.47

8.7

6.3

1.46

1.30

mmol/l

0.55

140

646

(40768797) Stomach Pathology biopsy report

499

3377

1.57

17.44

1.3

1.2

—

(3028433) Virus identified in Specimen by Culture

5.20

17.21

1.5

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

127

559

2.33

17.13

1.2

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

115

486

2.42

16.99

1.2

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

232

3.07

16.55

1.7

1.4

44592.07

83374.40

e6/l

0.48

134

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

148

705

2.16

16.50

1.7

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

197

1050

1.94

16.16

2.4

1.6

8.28

6.59

iu/ml

0.36

229

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

713

5305

1.45

15.61

1.8

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

263

2.86

15.49

1.7

1.4

1754.39

4955.68

e6/l

0.47

184

(3045788) Cell count panel - Pleural fluid

216

3.05

15.32

1.7

1.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

7.02

15.26

14.4

8.5

5.26

6.08

mmol/l

0.65

(21494434) Karyotype in Bone marrow

229

2.97

15.05

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

307

2.68

15.03

3.5

2.6

1.59

g/24h

0.00

192

(3022493) Free Hemoglobin [Mass/volume] in Plasma

115

3.87

15.02

10.9

3.8

59.85

74.94

mg/l

0.73

(3025941) Bacteria identified in Stool by Culture

239

1387

1.79

14.98

1.4

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

397

2.46

14.90

1.2

1.1

120.64

115.07

0.83

364

(3018405) Lactate [Moles/volume] in Arterial blood

158

804

2.02

14.81

6.1

4.0

1.37

1.38

mmol/l

0.06

150

793

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

137

3.54

14.45

1.8

1.5

4.45

6.27

u/l

0.41

116

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

311

1965

1.65

14.30

3.6

2.7

56.01

69.05

ml/min/173m2

5.32

137

810

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2169

19555

1.39

14.15

4.9

4.1

14.71

14.70

pmol/l

0.06

2054

18007

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

104

457

2.32

14.13

1.4

1.3

48.55

41.47

u/l

0.17

394

(3052851) Hemolysis interference index of Serum or Plasma

132

652

2.07

13.44

3.7

3.3

2.36

2.03

index

0.18

337

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2812

26772

1.75

13.30

43.4

18.8

85.60

78.07

umol/l

10.26

2798

26491

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2798

26619

1.72

13.04

22.1

11.4

31.04

27.29

u/l

5.83

2764

25945

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

232

2.80

12.97

1.2

167.50

246.05

titre

0.29

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

420

2.30

12.76

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

978

7897

1.35

12.75

1.6

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

939

7535

1.36

12.75

5.9

3.1

0.03

0.17

estimate

0.65

381

2252

(3004775) Volume in Urine collected for unspecified duration

180

3.04

12.72

2.8

2.5

648.97

629.13

0.11

125

(4195642) Thrombophilia screening test

391

2.34

12.58

1.3

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

104

481

2.20

12.55

1.1

—

(3000330) Specific gravity of Urine by Test strip

203

1195

1.75

12.12

5.3

3.2

1.02

ratio

0.24

188

1088

(3035880) pH of Pleural fluid

111

3.55

11.83

1.4

7.40

7.41

0.05

(40757373) Influenza virus identified in Isolate

5.53

11.64

2.3

1.8

—

(3046861) Legionella sp Ag [Presence] in Urine

30.14

11.64

1.4

1.0

—

(40768795) Lymph node Pathology biopsy report

225

2.70

11.44

1.6

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

254

2.59

11.43

1.6

1.5

—

(3002256) Pathology report gross observation

453

3272

1.45

11.25

1.4

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

146

801

1.86

11.02

1.4

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

480

3519

1.43

10.99

2.8

2.7

153.68

126.31

ug/g

0.88

395

2835

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

604

4617

1.39

10.86

1.4

1.3

43.91

29.63

iu/ml

1.38

184

1374

(21494890) Protein electrophoresis panel - 24 hour Urine

255

2.54

10.84

2.4

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.75

10.57

3.4

3.2

4.72

4.89

kpa

0.48

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.75

10.57

3.4

3.2

9.85

10.34

kpa

0.36

(3000060) B lymphocytes [#/volume] in Blood

3.66

10.51

1.8

2.0

0.19

0.29

e9/l

0.55

(3017732) Neutrophils [#/volume] in Blood

442

3217

1.44

10.50

4.6

3.2

4.40

4.77

e9/l

0.74

379

2821

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

130

700

1.90

10.41

1.2

1.1

3.80

3.66

0.07

105

(3016750) Collection duration of Urine

142

3.06

10.35

3.0

2.4

480.07

499.18

min

0.41

108

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

102

3.46

10.28

1.4

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

106

535

2.02

10.25

6.2

4.1

—

(3009871) Measles virus Ab [Titer] in Serum

113

3.30

10.12

1.3

1.6

3280.00

2448.00

titre

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

205

2.66

10.09

1.2

1.1

—

(3020891) Body temperature

190

1156

1.69

10.09

7.7

4.3

36.98

36.92

°c

1.66

185

1147

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

110

567

1.98

10.03

5.4

2.1

1.00

0.85

nmol/l

1.06

101

481

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

238

2.51

9.77

1.2

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

555

4253

1.37

9.72

1.4

1.3

17.93

10.56

u/ml

1.06

198

1692

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

295

2.34

9.62

2.3

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

199

2.64

9.59

1.2

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

5.03

9.56

1.8

2.9

15.25

15.39

ml/dl

0.07

(3044242) Glucose [Moles/volume] in Arterial blood

144

2.94

9.50

2.0

2.2

8.10

7.90

mmol/l

0.12

144

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

206

2.60

9.48

1.2

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

159

938

1.73

9.46

1.4

1.3

142.42

230.28

miu/ml

2.98

413

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.12

9.43

2.7

1.4

—

(3018333) Ribosomal P Ab [Presence] in Serum

195

2.64

9.42

1.2

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

255

2.42

9.38

1.2

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

769

6231

1.31

9.21

1.4

1.3

1.65

1.64

u/ml

0.01

201

1699

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

215

2.54

9.21

4.3

2.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

643

5085

1.34

9.12

1.9

1.7

464.29

32737414.96

pmol/l

4.57

557

4304

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2335

21771

1.32

9.08

40.9

18.7

331.19

333.34

g/l

21.76

2330

21634

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

206

2.55

8.97

1.2

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

292

2.29

8.95

2.4

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

161

969

1.70

8.93

1.8

1.7

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

201

2.56

8.89

1.2

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

213

2.51

8.88

1.2

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

129

2.97

8.77

1.9

1.3

—

(3010813) Leukocytes [#/volume] in Blood

2865

27723

1.68

8.71

51.5

22.4

7.42

6.70

e9/l

9.85

2819

27135

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2481

23376

1.35

8.68

7.9

6.0

40.44

38.91

mmol/mol

10.79

2378

22069

(3047189) Immunofixation for 24 hour Urine

115

3.07

8.54

1.9

1.8

—

(3035941) MCH [Entitic mass]

2863

27713

1.66

8.50

51.2

22.3

30.16

30.31

4.15

2854

27452

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2863

27714

1.66

8.49

51.2

22.3

90.98

90.75

1.77

2854

27454

(3007461) Platelets [#/volume] in Blood

2862

27702

1.66

8.48

51.5

22.4

249.62

248.98

e9/l

0.19

2822

27197

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.36

8.48

3.1

2.7

0.61

mmol/l

0.10

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2863

27715

1.66

8.47

55.5

22.8

39.62

41.56

6.81

2852

27440

(3026361) Erythrocytes [#/volume] in Blood

2863

27717

1.66

8.44

51.3

22.3

4.43

4.55

e12/l

24.12

2819

27143

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

116

3.04

8.42

1.3

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

294

2.24

8.39

2.4

1.4

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

3.48

8.36

1.5

64.50

59.52

0.25

(3007566) Smooth muscle Ab [Titer] in Serum

131

759

1.76

8.34

1.2

1.3

117.00

84.81

titre

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.32

8.34

1.2

1.4

100.00

88.94

0.87

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

131

760

1.76

8.30

2.2

2.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

2863

27727

1.65

8.30

51.9

22.5

131.83

136.92

g/l

52.00

2854

27464

(3027456) Digoxin [Moles/volume] in Serum or Plasma

422

2.02

8.29

3.6

3.4

0.87

0.81

nmol/l

0.50

344

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

128

2.91

8.27

1.9

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

101

543

1.89

8.20

3.2

2.5

186.50

105.97

ug/min

0.79

336

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

114

638

1.82

8.16

1.5

84.06

32.32

e6/l

0.46

472

(3022145) Colonoscopy Study observation

385

2856

1.40

8.13

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

328

2366

1.43

8.11

3.6

4.4

4.84

17.22

ug/l

2.68

267

1925

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

108

597

1.84

8.05

1.3

1.2

1.35

4.04

u/ml

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2514

23798

1.34

8.02

5.7

4.8

6.11

5.90

mmol/l

10.05

2392

22020

(3003181) Sodium [Moles/volume] in Urine

432

1.97

7.79

2.1

1.4

66.66

63.97

mmol/l

0.21

345

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

114

648

1.79

7.77

1.6

1.5

834.49

1200.03

e6/l

0.26

503

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

228

1549

1.51

7.66

3.8

3.6

4.33

4.55

pmol/l

2.95

205

1388

(3001893) Eosinophils/Leukocytes in Pleural fluid

3.49

7.54

1.4

1.5

2.84

2.13

0.19

(3009466) Valproate [Moles/volume] in Serum or Plasma

410

1.98

7.50

6.8

5.9

381.33

370.81

umol/l

0.26

362

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.14

7.40

1.9

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.14

7.40

1.1

1.2

96.67

87.29

0.94

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.14

7.40

1.9

1.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

13.38

7.38

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

4.02

7.34

1.1

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

190

2.44

7.33

1.9

1.1

89.54

107.91

pmol/l

1.88

190

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

456

1.91

7.32

1.2

1.1

69.88

117.68

iu/ml

0.34

110

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1184

10339

1.24

7.31

6.1

3.6

0.00

0.08

estimate

1.04

401

2359

(3036525) Urea [Moles/time] in 24 hour Urine

9.37

7.28

2.8

4.1

—

(3008295) Osmolality of Serum or Plasma

299

2.13

7.27

1.2

1.4

283.11

280.93

mosm/kgh2o

0.23

229

(3044290) Cell count panel - Cerebral spinal fluid

105

599

1.78

7.10

1.4

1.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

122

727

1.71

7.08

1.5

1.4

835.47

548.61

mg/l

0.67

115

695

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

122

729

1.70

7.01

1.4

1.2

6.03

7.42

u/ml

0.16

(1002224) Polysomnography panel

201

1356

1.52

6.99

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

184

2.41

6.85

15.4

16.6

909.30

822.63

nmol/l

0.51

178

(3034426) Prothrombin time (PT)

3.09

6.73

1.5

1.2

29.63

28.82

0.19

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

121

2.75

6.70

1.2

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

311

2.05

6.60

1.4

1.2

46.52

73.63

u/ml

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

120

727

1.68

6.57

1.4

1.2

3.86

2.45

u/ml

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

3.82

6.53

3.5

3.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

10.03

6.53

5.0

3.6

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

6.85

6.51

1.7

1.5

1.20

2.43

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

6.85

6.51

1.7

1.5

4.87

1.51

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

6.85

6.51

1.7

1.5

5.75

4.32

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

6.85

6.51

1.7

1.5

3.62

0.99

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

6.85

6.51

1.7

1.5

0.98

2.03

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

6.85

6.51

1.7

1.5

3.32

3.88

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

6.85

6.51

1.7

1.5

0.44

2.61

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

6.85

6.51

1.7

1.5

1.47

2.39

mg/l

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

382

1.93

6.50

1.1

4.34

3.25

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

122

745

1.66

6.49

1.5

1.4

264.97

280.24

ug/g

0.35

430

(3025468) Yersinia sp identified in Specimen by Organism specific culture

286

2.08

6.49

2.3

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

109

646

1.71

6.48

1.7

1.4

—

(40768441) Liver Pathology biopsy report

183

2.37

6.46

1.5

—

(36660697) Celiac disease serology panel - Serum

293

2159

1.40

6.42

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

288

2.07

6.38

2.3

1.4

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

6.55

6.33

1.7

1.5

5.52

1.38

mg/l

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

289

2.06

6.32

2.3

1.4

—

(3023410) Appearance of Cerebral spinal fluid

296

2.05

6.31

1.3

1.7

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.85

6.25

1.6

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.85

6.25

1.6

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.85

6.25

1.6

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

363

1.92

6.07

1.2

1.1

—

11.01

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.69

6.03

1.5

1.2

1.95

1.15

iu/ml

—

(3019832) Treponema pallidum Ab [Presence] in Serum

423

3332

1.31

6.00

2.0

1.9

—

(4015189) Microbial culture of sputum

3.88

5.98

3.6

1.8

—

(3028707) Methadone [Presence] in Urine by Screen method

102

609

1.70

5.93

3.0

2.9

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

7.25

5.92

2.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

240

1735

1.42

5.88

1.3

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

124

2.60

5.87

2.0

2.9

96.00

124.35

umol/l

0.41

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

382

1.88

5.85

1.1

1.57

1.49

g/l

0.63

352

(3029937) Albumin [Presence] in Urine by Test strip

863

7428

1.23

5.80

6.6

3.8

0.00

estimate

1.74

413

2617

(3022621) pH of Urine by Test strip

272

2018

1.38

5.74

3.2

2.4

5.99

6.10

1.43

204

1340

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

3.92

5.71

3.6

3.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

295

1.99

5.65

1.6

1.3

0.19

0.25

nmol/l

0.40

236

(3015171) Extractable nuclear Ab [Units/volume] in Serum

144

949

1.54

5.63

1.3

1.2

1.69

0.77

u/ml

—

(3016018) Differential panel - Cerebral spinal fluid

317

1.94

5.59

1.3

1.5

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

283

2.00

5.56

1.7

20.40

27.57

ug/l

0.64

278

(44816559) Phosphatidylethanol [Mass/volume] in Blood

186

1303

1.46

5.43

2.0

1.7

0.22

0.31

mg/l

2.31

646

(3011288) Drugs identified in Urine by Screen method Nominal

155

1047

1.51

5.42

4.1

2.9

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

105

649

1.64

5.39

1.4

3.92

3.72

mmol/l

0.97

615

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.88

5.34

3.7

5.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

402

1.81

5.32

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.79

5.30

1.6

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

352

1.87

5.29

1.6

1.4

0.13

0.31

nmol/l

—

(3037121) Protein [Mass/volume] in Urine

139

923

1.53

5.27

4.2

3.4

867.78

312.30

mg/l

0.90

437

(3006571) Granulocytes/Leukocytes in Synovial fluid

250

2.02

5.14

1.7

1.6

60.71

60.27

0.03

162

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

574

1.66

5.08

1.3

1.2

35.69

47.22

u/ml

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

147

2.33

5.00

1.0

1.1

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

4.71

4.98

1.5

1.8

14.88

9.32

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.89

4.95

1.2

1.3

0.59

0.25

iu/ml

—

(3026389) Candida sp identified in Specimen by Organism specific culture

332

1.85

4.91

1.6

1.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

136

2.37

4.90

3.5

1.7

2.19

1.85

umol/l

0.92

123

(1001926) Buprenorphine [Presence] in Urine by Screen method

168

1183

1.44

4.80

2.4

2.1

—

(3051611) Lipemic interference index of Serum or Plasma

216

2.05

4.77

4.7

3.4

16.42

13.45

index

0.77

129

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

484

1.69

4.77

1.1

15.54

14.43

au/ml

—

128

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

5.22

4.76

1.5

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

140

953

1.49

4.76

1.7

1.6

29.65

14.15

u/ml

0.58

231

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

286

1.90

4.74

1.4

—

nmol/l

—

(40768443) Skin Pathology biopsy report

155

1079

1.46

4.71

1.3

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.22

4.61

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

8.20

4.56

5.3

5.2

532.00

429.36

umol/l

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

193

2.09

4.55

1.0

1.1

17.57

9.19

iu/ml

—

(3000475) Leukocytes [#/volume] in Synovial fluid

615

1.60

4.55

1.9

1.6

17583.76

15277.91

e6/l

0.09

429

(4024509) Urine culture

157

1104

1.45

4.54

2.0

1.9

—

(3010838) Calcium [Moles/time] in 24 hour Urine

416

1.72

4.51

2.0

1.9

4.94

4.99

mmol/24h

0.04

369

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2451

23518

1.23

4.50

4.9

4.1

1.45

1.30

mmol/l

15.56

2322

21896

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

6.68

4.46

4.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

149

2.23

4.43

1.1

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

150

2.21

4.37

1.5

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

3.10

4.36

1.6

1.4

531.02

26.03

g/l

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

3.35

4.32

1.1

1.2

—

225.20

titre

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

206

2.00

4.21

1.0

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

102

2.46

4.21

1.1

102.95

93.99

0.48

(3011985) Renin [Units/volume] in Plasma

354

1.74

4.04

1.5

1.4

70.44

68.88

mu/l

0.02

317

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

10.02

4.01

16.4

11.0

—

(3016879) Cocaine [Presence] in Urine

188

1399

1.37

3.96

2.4

2.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

137

2.20

3.95

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

4.08

3.90

2.0

1.4

—

(3045414) Leukocytes [Presence] in Urine

298

2375

1.28

3.88

2.6

2.0

0.05

0.01

estimate

0.37

497

(4034850) Laboratory test

751

0.54

3.87

21.7

9.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

256

1.85

3.85

1.1

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.69

3.82

1.8

1.4

12.24

12.56

g/l

0.04

(3049717) Cytology report of Urine Cyto stain

129

906

1.44

3.80

2.4

2.5

—

(3006653) Thiamine [Moles/volume] in Blood

146

2.13

3.80

1.3

136.10

135.33

nmol/l

0.03

146

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.54

3.79

2.2

2.9

28.50

30.22

umol/l

0.12

(40765096) Chromosome analysis panel by Banding

2.54

3.79

1.0

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

8.77

3.77

2.1

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

8.77

3.77

1.9

1.4

60.86

32.63

umol/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

140

2.15

3.76

1.6

1.8

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.51

3.71

1.0

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

141

2.14

3.70

4.1

1.7

26.77

27.66

umol/l

0.23

131

(3026480) Teichoate Ab [Titer] in Serum

5.01

3.68

1.0

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.87

3.62

1.1

1.3

41.38

132.49

ug/l

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

217

2774

0.77

3.54

10.4

6.4

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

4.24

3.50

1.3

1.2

19.50

23.25

u/l

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

10.02

3.49

2.2

11.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

243

1.82

3.48

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

112

2.24

3.48

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

725

0.56

3.46

1.3

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

127

907

1.42

3.45

3.2

3.5

43.93

4710.78

u/ml

0.92

105

789

(3000764) Benzodiazepines [Presence] in Urine

196

1505

1.32

3.40

2.3

2.1

—

(44806071) Cardiolipin IgM antibody measurement

3.76

3.38

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

209

1622

1.31

3.36

1.3

32.56

52.17

au/ml

0.88

122

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

582

1.51

3.31

1.3

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

115

2.18

3.28

1.2

1.1

—

(3028300) Cannabinoids [Presence] in Urine

196

1518

1.31

3.21

2.3

2.1

—

(3027008) Opiates [Presence] in Urine

195

1512

1.31

3.17

2.3

2.1

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

200

1.86

3.16

1.9

1.5

32.01

30.22

0.10

126

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

159

1199

1.34

3.14

2.2

2.3

—

(3024869) Neuronal Ab [Presence] in Serum

3.26

3.13

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

152

1.98

3.09

1.8

1.4

1.01

1.25

nmol/l

0.46

113

(3019225) pH of Specimen

276

2244

1.25

3.09

9.9

4.1

7.38

7.35

4.59

229

1621

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

4.01

3.08

2.0

1.6

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

4.30

2.99

1.4

2.7

4.67

3.11

mg/l

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

222

1768

1.28

2.96

2.3

2.4

12.31

20.94

au/ml

2.36

197

(3027944) Amphetamines [Presence] in Urine

191

1494

1.30

2.93

2.3

2.0

—

(3025130) Human papilloma virus identified in Specimen

358

1.60

2.90

2.0

1.9

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

3.45

2.89

1.5

1.2

8.00

44.38

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2584

25153

1.19

2.87

6.0

5.4

2.65

2.72

mmol/l

3.25

2446

23629

(40760409) HLA-A [Type] by High resolution

6.68

2.87

1.0

—

(40763590) HLA-DQ beta [Type]

6.68

2.87

1.0

—

(3013862) HLA-DP [Type]

6.68

2.87

1.0

—

(46236302) HLA-C [Type] by High resolution typing

6.68

2.87

1.0

—

(40760410) HLA-B [Type] by High resolution

6.68

2.87

1.0

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.77

2.81

1.5

1.4

0.13

0.71

u/ml

0.84

(3009214) Lutropin [Units/volume] in Serum or Plasma

128

952

1.36

2.79

1.5

7.64

8.01

u/l

0.15

761

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

209

1.78

2.78

1.6

1.9

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

110

2.10

2.78

1.1

1.6

1.44

1.99

u/field

0.34

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

8.34

2.75

1.0

266.28

240.17

nmol/l

—

(3047185) IgG [Mass/volume] in Urine

8.34

2.75

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

203

1.78

2.73

2.6

2.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

509

1.49

2.73

6.7

3.3

37.66

27.20

mg/l

1.33

350

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

111

2.08

2.72

1.2

750.00

952.17

titre

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

6.01

2.70

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

398

3410

1.19

2.68

1.6

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

688

1.41

2.63

1.1

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

159

1233

1.31

2.63

1.4

20.58

22.51

iu/l

0.34

124

1041

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

162

1.86

2.62

1.1

1430.03

1434.43

miu/ml

0.01

162

(3023383) Lactate [Moles/volume] in Pleural fluid

2.47

2.61

1.3

1.6

3.10

3.12

mmol/l

0.01

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

2.26

2.60

1.3

1.1

5.40

18.63

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

196

2436

0.79

2.60

1.7

3.45

3.49

mmol/l

0.17

126

1643

(3004446) Plasmodium sp identified in Blood by Light microscopy

3.34

2.60

2.9

2.6

—

(3016135) IgD [Mass/volume] in Serum

7.15

2.55

1.0

17.82

42.36

mg/l

—

(3032057) Clostridioides difficile [Presence] in Stool

2.73

2.54

2.3

2.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

685

1.40

2.53

1.1

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

186

1.78

2.53

1.1

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

262

2170

1.23

2.51

2.3

2.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.17

2.50

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

636

1.41

2.50

1.2

1.1

2.48

2.44

u/ml

0.02

337

(3021387) Prolactin [Units/volume] in Serum or Plasma

143

1107

1.31

2.42

1.9

1.6

336.36

284.18

mu/l

1.09

131

1014

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

131

1.92

2.40

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.01

2.40

2.0

1.9

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.01

2.40

6.2

3.8

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.35

2.38

1.2

8.77

9.06

pmol/l

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.62

2.35

1.3

1.2

1.18

1.19

mmol/l

0.08

(3015076) Soybean IgE Ab [Units/volume] in Serum

161

1.81

2.35

1.1

1.0

1.79

2.41

u/ml

0.10

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

291

1.59

2.33

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

696

1.38

2.33

1.1

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

242

2900

0.82

2.31

4.9

4.7

32.27

31.76

0.27

181

1980

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.19

2.31

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.48

2.27

1.0

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

164

1.78

2.23

1.4

22.00

20.00

u/ml

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

240

1.63

2.22

2.4

2.3

16.78

20.38

nmol/l

1.39

225

(3015956) Eosinophils/Leukocytes in Blood by Manual count

2.69

2.20

5.1

2.0

1.00

2.59

2.02

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

277

3260

0.83

2.19

2.0

1.9

3.76

3.59

ratio

1.31

209

2470

(3020874) Milk IgE Ab [Units/volume] in Serum

180

1.73

2.18

1.1

0.51

1.26

u/ml

0.84

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.34

2.18

2.3

4.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

560

1.40

2.17

1.1

6.87

5.62

u/ml

0.22

316

(3025577) Chromium [Mass/volume] in Blood

122

1.89

2.16

1.9

2.3

1.54

2.05

ug/l

0.79

104

(3030313) Adrenal Ab [Titer] in Serum

3.69

2.15

1.1

1.0

—

(3042517) Benzodiazepines panel - Urine

3.01

2.14

2.9

2.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

123

1.88

2.11

1.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.45

2.10

1.5

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

183

1.70

2.07

1.8

1.2

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.91

2.07

4.4

1.7

1.12

1.26

umol/l

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.91

2.07

1.4

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.01

2.07

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

5.01

2.07

2.0

2.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

432

1.44

2.05

1.1

10.51

4.34

u/ml

0.84

200

(3006442) Creatine [Moles/volume] in Serum or Plasma

184

1.69

2.04

1.7

1.4

94.13

81.90

umol/l

0.70

184

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

184

1.69

2.04

1.8

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.01

2.04

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

543

1.39

2.01

1.1

1.44

1.42

u/ml

0.01

236

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

411

3620

1.16

2.00

2.1

1.8

1.49

1.46

0.26

358

3225

(3014891) Appearance of Pleural fluid

2.82

2.00

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

536

1.39

1.99

1.1

2.58

1.55

u/ml

0.35

276

(3020491) Glucose [Moles/volume] in Blood

178

1.69

1.98

1.6

2.1

9.14

6.67

mmol/l

1.09

122

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2542

24860

1.14

1.96

5.4

4.8

4.50

4.60

mmol/l

5.56

2407

23453

(3038177) Helicobacter pylori Ab [Presence] in Serum

428

1.43

1.96

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

241

1.58

1.95

3.0

1.5

1.43

1.18

promille

0.41

196

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.55

1.94

7.8

7.9

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.76

1.93

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.76

1.93

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.45

1.93

1.1

1.2

0.95

1.54

mmol/l

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

328

2851

1.17

1.90

2.7

2.4

12.11

13.59

nmol/l

2.96

299

2626

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

204

1.62

1.89

1.3

1.6

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.16

1.88

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.16

1.88

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

2.16

1.88

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.16

1.88

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

220

1.60

1.88

1.2

1.1

7.58

18.16

u/ml

—

(4198724) Urine methamphetamine measurement

151

1.73

1.87

2.5

1.9

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.03

1.85

1.3

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.53

1.83

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.13

1.81

1.3

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

711

1.32

1.80

2.0

2.1

3.74

11.71

iu/l

0.52

303

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.58

1.80

1.3

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

2.58

1.80

3.0

6.4

8.84

8.66

mmol/l

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

462

1.39

1.78

1.1

6.81

3.11

u/ml

0.94

238

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

345

1.46

1.78

1.4

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

159

1304

1.23

1.75

1.5

1.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.34

1.74

1.3

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

2.50

1.74

1.6

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1126

10608

1.10

1.72

2.2

1.9

1.58

1.39

mmol/l

7.82

994

9088

(3014599) Egg white IgE Ab [Units/volume] in Serum

178

1.64

1.72

1.3

1.1

7.98

1.21

u/ml

0.72

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.14

1.71

1.1

1.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2524

24720

1.13

1.71

5.4

4.8

1.35

1.42

mmol/l

15.18

2377

23180

(3034274) Bile acid [Moles/volume] in Serum --fasting

390

1.42

1.71

2.2

10.15

7.16

umol/l

0.29

292

(3047352) Trisomy 18 risk [Likelihood] in Fetus

639

1.32

1.70

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

563

1.34

1.66

1.5

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.80

1.65

1.0

—

(3005033) Fetal Nuchal fold Thickness US

625

1.32

1.64

1.5

1.24

1.26

0.18

458

(3019420) Tryptase [Mass/volume] in Serum or Plasma

150

1.67

1.63

3.0

1.7

28.34

9.18

ug/l

0.70

134

(4281824) Cell count and differential, peritoneal fluid

213

1.56

1.62

1.2

1.1

—

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

3.58

1.61

2.2

1.2

11.20

17.63

—

(40758292) HTLV I+II Ab panel - Serum

2.15

1.61

1.8

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

173

1446

1.21

1.61

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.50

1.59

1.1

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

507

1.35

1.59

2.5

3.6

66.51

832.98

u/ml

0.90

476

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

3.00

1.58

1.0

1.1

—

30.29

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.70

1.58

2.6

1.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

159

0.44

1.54

1.0

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.34

1.52

1.6

1.4

297.80

337.13

umol/24h

—

(3007463) Buprenorphine [Presence] in Urine

3.34

1.52

4.2

5.8

—

(3024263) Appearance of Synovial fluid

123

1.71

1.50

1.7

—

(3044927) Protein electrophoresis panel - Urine

244

1.48

1.44

1.1

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

207

1780

1.17

1.43

1.3

1.2

71.63

133.90

u/ml

3.45

661

(3005011) Chlamydia sp Ab [Titer] in Serum

2.25

1.40

1.8

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

211

1822

1.17

1.39

2.2

2.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

652

1.28

1.38

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.20

1.37

1.0

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.94

1.36

1.2

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

155

1308

1.20

1.34

1.4

1.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

183

1.54

1.34

1.5

1.9

3.65

1.54

u/field

0.58

100

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

773

1.25

1.31

1.4

1.5

1.22

1.11

ratio

0.70

481

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

411

1.34

1.31

1.1

1.02

0.26

u/ml

0.58

139

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.74

1.31

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

774

1.25

1.30

1.4

1.5

0.91

0.95

ratio

0.59

482

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

774

1.25

1.30

1.4

1.5

1.24

1.20

ratio

0.14

486

(3050794) Legionella sp Ab [Presence] in Serum

2.50

1.30

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.50

1.30

1.0

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

2.10

1.30

1.1

1.3

60.56

67.51

ug/l

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.36

1.29

1.3

1.1

64.00

88.47

titre

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.78

1.28

4.4

2.9

0.82

0.64

ug/l

—

(3002619) Bacteria identified in Specimen by Culture

1.94

1.27

1.1

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.29

1.26

1.0

—

(44813793) Dust mix specific IgE antibody measurement

170

1.53

1.26

1.1

1.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

1.74

1.25

2.6

2.3

233.91

858.93

e6/l

2.72

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

761

1.24

1.4

1.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.63

1.21

13.0

5.0

—

(3034891) Synovial lining cells/cells in Synovial fluid

101

1.69

1.19

1.8

1.5

1.50

4.41

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.83

1.19

1.5

1.4

8.93

8.79

ug/l

0.04

(3032773) Endomysium IgG Ab [Titer] in Serum

264

1.41

1.18

1.1

—

(3017704) Immunofixation for Urine

141

1.56

1.17

2.9

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

963

9142

1.08

1.16

4.6

5.1

2.82

2.67

ug/l

0.06

891

8335

(3004616) Nuclear Ab [Presence] in Serum

309

1.36

1.13

1.5

1.2

—

(40768793) Breast Pathology biopsy report

494

0.73

1.12

1.4

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.78

1.10

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.26

1.10

1.1

1.2

—

(44806420) Estimation of glomerular filtration rate

260

1.39

1.09

2.8

2.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1157

0.82

1.09

1.1

1.2

1.47

1.50

g/l

0.41

1157

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.38

1.09

1.2

3.0

0.40

0.57

u/field

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

194

1.45

1.06

2.0

1.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

339

1.33

1.06

2.0

1.5

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.12

1.05

1.4

1.2

—

640.53

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.71

1.05

1.4

1.2

112.67

106.32

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

645

0.77

1.04

1.9

1.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

323

1.34

1.04

1.0

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.06

1.03

1.0

1.3

—

(21494755) Public health laboratory ask at order entry panel

249

2772

0.89

1.02

1.4

1.3

—

(3033099) Centromere Ab [Titer] in Serum

1.88

1.00

1.0

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

115

1.57

0.99

1.1

1.3

180.44

170.13

mmol/24h

0.17

115

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

1.71

0.98

1.2

1.9

11760.00

24566.94

e6/l

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.95

0.97

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

100

1.60

0.96

1.3

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.74

0.96

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

242

1.37

0.94

4.3

5.3

129.99

52.86

u/ml

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

208

1.40

0.94

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.22

0.93

1.7

—

(4038314) Semen analysis, post vasectomy

2.15

0.91

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

838

1.19

0.90

1.5

1.6

63.69

59.26

ug/l

0.48

715

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.75

0.90

1.7

1.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

272

1.33

0.87

3.8

3.0

9.90

25.81

nmol/l

0.35

266

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

0.87

1.2

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.78

0.84

1.0

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.69

0.82

1.2

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.88

0.81

1.2

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

582

5497

1.07

0.81

2.9

3.1

0.72

0.74

ug/l

0.22

407

3419

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

419

1.25

0.79

1.2

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1095

0.85

0.79

1.1

0.69

0.64

ratio

0.49

122

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.82

0.79

1.2

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.82

0.79

1.0

1.2

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.67

0.78

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

1.53

0.78

2.8

2.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

735

0.83

0.76

1.7

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.64

0.75

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.60

0.74

3.0

3.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

175

1.37

0.74

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.09

0.74

1.0

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

227

1.32

0.74

1.9

1.3

176477.88

106838.94

e6/l

0.30

156

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.67

0.74

1.4

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.84

0.73

1.0

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

135

1195

1.14

0.73

3.1

2.4

4777.59

6446.90

u/l

0.29

480

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

361

1.25

0.73

1.0

1.35

2.29

eliau/ml

1.70

164

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.00

0.72

1.0

—

(3044007) Cell count panel - Peritoneal fluid

1.58

0.71

2.8

1.9

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.92

0.70

1.2

1.0

—

(3006270) Folate [Moles/volume] in Blood

177

1.36

0.70

1.0

1.1

369.75

392.23

nmol/l

0.20

158

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

126

1.43

0.70

1.7

2.0

2.17

1.06

u/ml

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.85

0.68

1.0

5.68

7.46

u/ml

—

(3044009) aPTT.lupus sensitive (LA screen)

1.85

0.68

1.0

1.2

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

118

0.59

0.67

3.7

6.4

5.14

8.25

—

118

(40761995) Spermatozoa Progressive [#/volume] in Semen

118

0.59

0.67

1.9

3.2

41.86

45.24

—

118

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

111

1.44

0.65

2.3

2.5

—

(3000034) Microalbumin [Mass/volume] in Urine

202

0.69

0.65

1.6

2.9

15.22

33.58

mg/l

—

154

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

188

0.69

0.62

1.8

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

566

0.83

0.61

1.3

1.5

49.63

61.00

ug/l

1.65

566

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.67

0.61

1.2

2.8

—

(3001556) Androgen free Index in Serum or Plasma

1.67

0.61

1.0

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

334

0.78

0.60

1.3

6.16

7.13

mmol/l

1.71

298

(37021550) Renin [Units/volume] in Plasma --upright

1.54

0.59

1.5

1.3

46.42

64.79

mu/l

—

(3020650) Glucose [Presence] in Urine

1.45

0.59

1.5

1.8

0.00

0.06

estimate

0.80

(3032868) Hemoglobin electrophoresis panel in Blood

1.72

0.57

1.8

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.67

0.56

1.0

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

410

3884

1.06

0.56

2.4

2.3

—

(3018133) Calcium [Moles/volume] in Urine

1.43

0.52

4.6

2.6

2.07

2.60

mmol/l

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.50

0.51

1.8

2.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.41

0.51

1.0

1.1

34.23

47.25

iu/ml

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

377

3576

1.06

0.51

2.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.49

0.49

1.2

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

110

0.64

0.48

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.45

0.48

1.1

1.7

60.06

187.67

nmol/24h

0.88

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.47

0.47

1.2

1.1

—

(4211845) Urine protein measurement

111

1.35

0.46

2.8

2.6

—

(3019150) Specific gravity of Urine by Refractometry

630

6078

1.05

0.46

5.4

3.7

1.02

1.52

kg/l

0.80

477

4036

(3039443) Prostate specific Ag panel - Serum or Plasma

578

0.86

0.45

1.4

1.6

—

(1761868) Lipid panel - Serum or Plasma

1066

10404

1.04

0.44

3.5

3.0

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.56

0.42

1.0

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

709

1.12

0.41

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.47

0.40

1.0

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.47

0.40

15.0

6.4

0.16

0.21

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

169

1.24

0.38

2.5

2.0

1.94

589.71

pmol/l

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

429

1.14

0.38

1.6

1.5

0.30

0.36

nmol/l

0.33

342

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

677

1.11

0.37

1.1

6.23

5.34

eliau/ml

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

110

1014

1.09

0.36

1.7

6.66

4.90

mg/l

0.52

733

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.43

0.35

1.8

2.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.28

0.32

2.0

2.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

183

1.20

0.31

1.1

1.2

0.57

0.59

ratio

0.07

105

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

115

1070

1.08

0.31

3.0

34.67

72.44

u/ml

1.97

108

1034

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.32

0.30

1.6

3.0

4.47

52.88

ug/l

—

(3022689) Creatine [Moles/volume] in Urine

1.32

0.28

1.7

1.3

9.03

9.15

mmol/l

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

746

7299

1.03

0.28

3.7

4.2

22.65

21.80

0.68

341

3371

(3045424) Erythrocytes [Presence] in Urine

130

1223

1.07

0.28

2.7

2.1

0.08

0.67

estimate

0.43

381

(40768800) Prostate Pathology biopsy report

543

0.90

0.27

1.2

—

(4146454) Self-monitoring of blood glucose

262

1.15

0.26

3.4

2.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

364

3528

1.04

0.25

1.6

1.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

116

1.21

0.22

1.6

0.53

0.48

e9/l

0.37

116

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.21

0.0

1.0

—

0.22

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

7.91

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.17

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.20

0.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

112

0.80

0.20

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.21

0.19

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.18

0.19

1.7

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

279

1.11

0.19

2.0

2.2

38.20

19.97

mg/l

—

109

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

242

1.12

0.18

1.1

43.16

42.65

mg/l

0.03

202

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

154

1481

1.04

0.18

1.5

1.6

920.28

1011.34

mu/l

0.81

129

1268

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.13

0.17

1.1

1.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.13

0.17

17.4

7.4

4.86

5.32

kpa

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.18

0.16

1.5

1.4

—

(4133840) Spirometry

1.11

0.16

1.5

1.2

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.78

0.15

1.2

1.1

65.75

59.44

u/ml

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.14

0.15

2.3

1.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

507

1.07

0.15

2.3

1.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

348

0.92

0.15

1.9

1.6

355.61

336.19

mu/l

0.09

283

(3043410) Blood group antigens tested for on Red Blood Cells

0.79

0.14

1.6

1.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

158

0.89

0.12

1.1

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

101

974

1.04

0.12

1.2

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

187

0.91

0.10

1.1

1.06

1.09

u/l

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.14

0.10

24.0

7.6

9.62

10.68

—

(3008898) HLA-B27 [Presence]

971

0.97

0.10

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

1.13

0.09

2.2

2.6

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

146

1.10

0.08

1.1

1.2

10.62

8.08

mm/h

0.42

146

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

101

1.09

0.04

1.1

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

260

1.04

0.03

1.3

1.4

162.46

203.07

pmol/l

0.51

260

(3005570) Glucose [Moles/volume] in Urine

242

1.03

0.02

2.2

2.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

759

0.99

0.01

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

225

1.02

0.00

1.0

1.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.96

-0.00

1.9

2.2

20.64

16.55

umol/l

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.9

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.0

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

-0.00

0.0

2.5

—

1072.33

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.91

-0.00

6.8

1.8

40.60

40.41

g/l

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

26.93

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

7.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint VIRALPNEUMONAS and mortality.

Females

Parameter	HR [95% CI]	p-value
VIRALPNEUMONAS	2.255 [1.88, 2.71]	< 0.001
Birth year	1.0 [0.99, 1.01]	0.902

During the follow-up period (1.1.1998 — 31.12.2019), 827 out of 3529 females with VIRALPNEUMONAS died.

Males

Parameter	HR [95% CI]	p-value
VIRALPNEUMONAS	2.692 [2.21, 3.28]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.023

During the follow-up period (1.1.1998 — 31.12.2019), 901 out of 3975 males with VIRALPNEUMONAS died.

Mortality risk

Mortality risk for people of age

years, who have VIRALPNEUMONAS.

N-year risk	Females	Males
1	0.203%	0.548%
5	1.273%	3.523%
10	3.244%	8.66%
15	6.991%	15.832%
20	12.016%	25.6%

Relationships between endpoints

↥

Index endpoint: VIRALPNEUMONAS – Viral pneumonia (unknown virus, not influenza)

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Viral pneumonia (unknown virus, not influenza)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints